ONTOLOGY REPORT - ANNOTATIONS
| Term: | calciol |
|
| Accession: | CHEBI:28940
|
browse the term
|
| Definition: | A seco-cholestane that has formula C27H44O. |
| Synonyms: | related_synonym: | (1S,3Z)-3-[(2E)-2-[(1R,3AR,7AS)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL; (3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol; (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol; C27H44O; CC; Cholecalciferol; InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1; InChIKey=QYSXJUFSXHHAJI-YRZJJWOYSA-N; Vitamin D3; [H][C@@]1(CC[C@]2([H])[C@]1(C)CCC\\C2=C/C=C1/C[C@@H](O)CCC1=C)[C@H](C)CCCC(C)C; activated 7-dehydrocholesterol; colecalciferol; oleovitamin D3; vitamin D3 |
| | alt_id: | CHEBI:10008; CHEBI:23170; CHEBI:46283 |
| | xref_casrn: | 67-97-0 |
| | xref: | Beilstein:2339331 "Beilstein Registry Number"; ChEMBL:225294 "ChEMBL COMPOUND"; ChemIDplus:67-97-0 "CAS Registry Number"; CiteXplore:15876428 "PubMed citation"; CiteXplore:19817701 "PubMed citation"; CiteXplore:9627702 "PubMed citation"; DrugBank:DB00169 "DrugBank"; Gmelin:1267613 "Gmelin Registry Number"; KEGG COMPOUND:67-97-0 "CAS Registry Number"; KEGG COMPOUND:C05443 "KEGG COMPOUND"; LIPID MAPS:LMST03020000 "LIPID MAPS instance"; LIPID MAPS:LMST03020001 "LIPID MAPS instance" |
| | xref_mesh: | MESH:D002762 |
| | xref: | NIST Chemistry WebBook:67-97-0 "CAS Registry Number"; PDBeChem:VD3 "PDBeChem"; Wikipedia:Vitamin_D "Wikipedia" |
|
|
calciol
|
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
decreases expression |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
increases expression |
ISO |
X |
36,168,547 |
36,232,162 |
RGD:6480464 |
CTD |
| G |
Acvr1 |
activin A receptor, type I |
|
increases expression |
ISO |
3 |
40,191,727 |
40,260,488 |
RGD:6480464 |
CTD |
| G |
Ada |
adenosine deaminase |
|
decreases expression |
ISO |
3 |
154,636,530 |
154,660,637 |
RGD:6480464 |
CTD |
| G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
decreases expression |
ISO |
1 |
199,780,772 |
199,791,855 |
RGD:6480464 |
CTD |
| G |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
|
increases expression |
ISO |
20 |
11,616,718 |
11,747,294 |
RGD:6480464 |
CTD |
| G |
Adm2 |
adrenomedullin 2 |
|
multiple interactions |
EXP |
7 |
127,620,056 |
127,621,802 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
decreases expression |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
increases expression |
ISO |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Arih1 |
ariadne homolog, ubiquitin-conjugating enzyme E2 binding protein, 1 (Drosophila) |
|
increases expression |
ISO |
8 |
63,201,871 |
63,305,302 |
RGD:6480464 |
CTD |
| G |
Arl5a |
ADP-ribosylation factor-like 5A |
|
increases expression |
ISO |
3 |
33,905,755 |
33,926,681 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases phosphorylation |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bambi |
BMP and activin membrane-bound inhibitor, homolog (Xenopus laevis) |
|
increases expression |
ISO |
17 |
62,654,385 |
62,658,641 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl7c |
B-cell CLL/lymphoma 7C |
|
decreases expression |
ISO |
1 |
186,993,655 |
186,997,484 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
multiple interactions |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
increases expression |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
multiple interactions |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
increases expression |
EXP |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
increases secretion |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bmp1 |
bone morphogenetic protein 1 |
|
increases expression |
ISO |
15 |
50,878,144 |
50,922,313 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
increases expression |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmpr1a |
bone morphogenetic protein receptor, type IA |
|
increases expression |
ISO |
16 |
10,061,943 |
10,105,854 |
RGD:6480464 |
CTD |
| G |
Brd8 |
bromodomain containing 8 |
|
increases expression |
ISO |
18 |
27,074,235 |
27,094,586 |
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Calcrl |
calcitonin receptor-like |
|
multiple interactions |
EXP |
3 |
67,553,022 |
67,646,877 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccng2 |
cyclin G2 |
|
increases expression |
ISO |
14 |
16,338,132 |
16,346,628 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
multiple interactions |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
increases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
multiple interactions |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cda |
cytidine deaminase |
|
increases expression |
ISO |
5 |
157,117,303 |
157,143,989 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
increases expression |
ISO |
18 |
8,048,920 |
8,267,974 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
multiple interactions |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases activity |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases phosphorylation |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
increases expression |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
|
increases expression |
ISO |
1 |
80,742,540 |
80,758,943 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Chrne |
cholinergic receptor, nicotinic, epsilon (muscle) |
|
decreases expression |
ISO |
10 |
57,497,192 |
57,501,511 |
RGD:6480464 |
CTD |
| G |
Cmpk2 |
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
|
increases expression |
ISO |
6 |
44,128,544 |
44,139,346 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
increases expression |
ISO |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Cpne3 |
copine III |
|
increases expression |
ISO |
5 |
34,154,672 |
34,203,959 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
increases expression |
ISO |
8 |
58,317,337 |
58,325,375 |
RGD:6480464 |
CTD |
| G |
Crcp |
CGRP receptor component |
|
increases expression |
ISO |
12 |
27,666,950 |
27,702,741 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
decreases expression |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Cxcr7 |
chemokine (C-X-C motif) receptor 7 |
|
increases expression |
ISO |
9 |
89,343,528 |
89,355,053 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
3 |
161,542,131 |
161,553,801 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
3 |
161,542,131 |
161,553,801 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
9 |
74,039,204 |
74,068,648 |
RGD:6480464 |
CTD |
| G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases expression |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases activity |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
decreases activity |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases hydroxylation |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
increases hydroxylation |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
increases expression |
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
decreases expression |
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Dab1 |
Dab, reelin signal transducer, homolog 1 (Drosophila) |
|
increases expression |
ISO |
5 |
125,434,133 |
125,694,562 |
RGD:6480464 |
CTD |
| G |
Dact1 |
dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis) |
|
increases expression |
ISO |
6 |
93,402,304 |
93,411,668 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
decreases expression |
ISO |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
increases expression |
ISO |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Enah |
enabled homolog (Drosophila) |
|
increases expression |
ISO |
13 |
97,919,690 |
98,025,153 |
RGD:6480464 |
CTD |
| G |
Epha4 |
Eph receptor A4 |
|
increases expression |
ISO |
9 |
76,676,778 |
76,820,752 |
RGD:6480464 |
CTD |
| G |
Erf |
Ets2 repressor factor |
|
decreases expression |
ISO |
1 |
80,518,385 |
80,527,142 |
RGD:6480464 |
CTD |
| G |
Etv4 |
ets variant 4 |
|
decreases expression |
ISO |
10 |
90,808,439 |
90,824,019 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
increases expression |
ISO |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
increases expression |
ISO |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
F8a1 |
coagulation factor VIII-associated 1 |
|
decreases expression |
ISO |
X |
159,089,210 |
159,090,724 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
decreases expression |
ISO |
1 |
250,951,023 |
250,956,730 |
RGD:6480464 |
CTD |
| G |
Flot1 |
flotillin 1 |
|
decreases expression |
ISO |
20 |
3,065,792 |
3,076,166 |
RGD:6480464 |
CTD |
| G |
Fosb |
FBJ osteosarcoma oncogene B |
|
increases expression |
ISO |
1 |
78,668,497 |
78,673,330 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
decreases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fpgs |
folylpolyglutamate synthase |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fst |
follistatin |
|
increases expression |
ISO |
2 |
46,542,246 |
46,550,678 |
RGD:6480464 |
CTD |
| G |
Fstl1 |
follistatin-like 1 |
|
increases expression |
ISO |
11 |
64,681,814 |
64,735,673 |
RGD:6480464 |
CTD |
| G |
Fzd9 |
frizzled family receptor 9 |
|
decreases expression |
ISO |
12 |
22,581,510 |
22,583,824 |
RGD:6480464 |
CTD |
| G |
Galk1 |
galactokinase 1 |
|
decreases expression |
ISO |
10 |
106,116,774 |
106,120,951 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
increases expression |
ISO |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gnai3 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
|
increases expression |
ISO |
2 |
203,668,275 |
203,706,229 |
RGD:6480464 |
CTD |
| G |
Grk5 |
G protein-coupled receptor kinase 5 |
|
increases expression |
ISO |
1 |
267,495,534 |
267,693,144 |
RGD:6480464 |
CTD |
| G |
Hhip |
Hedgehog-interacting protein |
|
increases expression |
ISO |
19 |
29,752,595 |
29,840,439 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hp |
haptoglobin |
|
increases expression |
ISO |
19 |
39,443,016 |
39,447,566 |
RGD:6480464 |
CTD |
| G |
Hspa4 |
heat shock protein 4 |
|
increases expression |
ISO |
10 |
38,705,629 |
38,749,058 |
RGD:6480464 |
CTD |
| G |
Ibsp |
integrin-binding sialoprotein |
|
multiple interactions |
ISO |
14 |
6,548,541 |
6,561,165 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
decreases expression |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
|
increases expression |
ISO |
17 |
72,557,196 |
72,563,149 |
RGD:6480464 |
CTD |
| G |
Ier2 |
immediate early response 2 |
|
decreases expression |
ISO |
19 |
25,159,276 |
25,160,800 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
decreases expression |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ifih1 |
interferon induced with helicase C domain 1 |
|
increases expression |
ISO |
3 |
44,547,092 |
44,593,969 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
increases expression |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
|
increases expression |
ISO |
10 |
87,822,429 |
87,834,315 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases expression |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Impad1 |
inositol monophosphatase domain containing 1 |
|
increases expression |
ISO |
5 |
18,086,121 |
18,109,691 |
RGD:6480464 |
CTD |
| G |
Itga6 |
integrin, alpha 6 |
|
increases expression |
ISO |
3 |
54,202,931 |
54,272,803 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
multiple interactions |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgax |
integrin, alpha X |
|
multiple interactions |
ISO |
1 |
187,396,184 |
187,416,273 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
increases expression |
ISO |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
increases expression |
ISO |
1 |
232,915,995 |
232,974,763 |
RGD:6480464 |
CTD |
| G |
Kcnab2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
|
decreases expression |
ISO |
5 |
169,624,099 |
169,710,725 |
RGD:6480464 |
CTD |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
decreases expression |
ISO |
1 |
79,613,736 |
79,628,887 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
increases expression |
ISO |
1 |
226,420,949 |
226,446,376 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
decreases expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Lamp2 |
lysosomal-associated membrane protein 2 |
|
increases expression |
ISO |
X |
6,908,285 |
6,951,772 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
increases expression |
ISO |
14 |
84,887,856 |
84,890,630 |
RGD:6480464 |
CTD |
| G |
Lrp2 |
low density lipoprotein receptor-related protein 2 |
|
increases expression |
ISO |
3 |
51,563,764 |
51,724,478 |
RGD:6480464 |
CTD |
| G |
Ltb4r |
leukotriene B4 receptor |
|
decreases expression |
ISO |
15 |
33,928,726 |
33,929,781 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
increases expression |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
|
decreases expression |
ISO |
5 |
151,873,619 |
151,885,483 |
RGD:6480464 |
CTD |
| G |
Mapk12 |
mitogen-activated protein kinase 12 |
|
increases expression |
ISO |
7 |
127,430,881 |
127,441,274 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
multiple interactions |
EXP |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Mgst3 |
microsomal glutathione S-transferase 3 |
|
decreases expression |
ISO |
13 |
83,038,049 |
83,058,802 |
RGD:6480464 |
CTD |
| G |
Mlph |
melanophilin |
|
decreases expression |
ISO |
9 |
90,113,308 |
90,149,114 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases activity |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mt-nd4 |
mitochondrially encoded NADH dehydrogenase 4 |
|
decreases expression |
ISO |
MT |
10,160 |
11,537 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases expression |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases response to substance |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Nckap1 |
NCK-associated protein 1 |
|
increases expression |
ISO |
3 |
63,191,700 |
63,274,021 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
affects expression |
EXP |
10 |
48,481,110 |
48,628,538 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
affects expression |
EXP |
12 |
32,617,643 |
32,725,753 |
RGD:6480464 |
CTD |
| G |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
|
increases expression |
ISO |
11 |
45,776,027 |
45,811,515 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
increases expression |
ISO |
3 |
4,631,797 |
4,677,640 |
RGD:6480464 |
CTD |
| G |
Nrd1 |
nardilysin 1 |
|
increases expression |
ISO |
5 |
130,345,980 |
130,408,734 |
RGD:6480464 |
CTD |
| G |
Nucks1 |
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
|
increases expression |
ISO |
6 |
142,904,062 |
142,905,783 |
RGD:6480464 |
CTD |
| G |
P4ha2 |
prolyl 4-hydroxylase, alpha polypeptide II |
|
increases expression |
ISO |
10 |
39,522,157 |
39,551,063 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
affects expression |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pbx1 |
pre-B-cell leukemia homeobox 1 |
|
increases expression |
ISO |
13 |
83,839,256 |
84,115,516 |
RGD:6480464 |
CTD |
| G |
Pbx2 |
pre-B-cell leukemia homeobox 2 |
|
increases expression |
ISO |
20 |
4,253,962 |
4,259,185 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
increases expression |
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Peli1 |
pellino E3 ubiquitin protein ligase 1 |
|
increases expression |
ISO |
14 |
101,870,272 |
101,924,228 |
RGD:6480464 |
CTD |
| G |
Phtf1 |
putative homeodomain transcription factor 1 |
|
increases expression |
ISO |
2 |
199,202,647 |
199,241,476 |
RGD:6480464 |
CTD |
| G |
Pik3c3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
|
multiple interactions |
ISO |
18 |
22,495,197 |
22,579,656 |
RGD:6480464 |
CTD |
| G |
Pik3c3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
|
increases expression |
ISO |
18 |
22,495,197 |
22,579,656 |
RGD:6480464 |
CTD |
| G |
Pik3c3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
|
multiple interactions |
ISO |
18 |
22,495,197 |
22,579,656 |
RGD:6480464 |
CTD |
| G |
Pitx2 |
paired-like homeodomain 2 |
|
increases expression |
ISO |
2 |
226,581,170 |
226,601,319 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases expression |
ISO |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plk2 |
polo-like kinase 2 |
|
increases expression |
ISO |
2 |
41,800,745 |
41,806,503 |
RGD:6480464 |
CTD |
| G |
Plod1 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
|
increases expression |
ISO |
5 |
164,987,252 |
165,012,581 |
RGD:6480464 |
CTD |
| G |
Pml |
promyelocytic leukemia |
|
multiple interactions |
ISO |
8 |
62,020,438 |
62,051,927 |
RGD:6480464 |
CTD |
| G |
Polr2i |
polymerase (RNA) II (DNA directed) polypeptide I |
|
decreases expression |
ISO |
1 |
85,489,089 |
85,490,526 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases expression |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Ptger3 |
prostaglandin E receptor 3 (subtype EP3) |
|
increases expression |
ISO |
2 |
255,680,691 |
255,759,202 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
increases expression |
ISO |
3 |
9,946,194 |
9,957,538 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
increases expression |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
decreases expression |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
multiple interactions |
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
decreases expression |
EXP |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
decreases secretion |
EXP |
1 |
171,240,596 |
171,243,528 |
RGD:6480464 |
CTD |
| G |
Pth1r |
parathyroid hormone 1 receptor |
|
increases expression |
ISO |
8 |
115,099,763 |
115,119,362 |
RGD:6480464 |
CTD |
| G |
Pum2 |
pumilio homolog 2 (Drosophila) |
|
increases expression |
ISO |
6 |
32,153,090 |
32,233,940 |
RGD:6480464 |
CTD |
| G |
Pxn |
paxillin |
|
increases expression |
ISO |
12 |
42,322,193 |
42,370,507 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
multiple interactions |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
increases response to substance |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Ramp1 |
receptor (G protein-coupled) activity modifying protein 1 |
|
multiple interactions |
EXP |
9 |
90,402,493 |
90,450,038 |
RGD:6480464 |
CTD |
| G |
Ramp2 |
receptor (G protein-coupled) activity modifying protein 2 |
|
increases expression |
ISO |
10 |
90,275,463 |
90,277,242 |
RGD:6480464 |
CTD |
| G |
Ramp2 |
receptor (G protein-coupled) activity modifying protein 2 |
|
multiple interactions |
EXP |
10 |
90,275,463 |
90,277,242 |
RGD:6480464 |
CTD |
| G |
Ramp3 |
receptor (G protein-coupled) activity modifying protein 3 |
|
multiple interactions |
EXP |
14 |
87,417,290 |
87,434,789 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
multiple interactions |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
multiple interactions |
EXP |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
increases expression |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
increases expression |
ISO |
1 |
242,443,795 |
242,450,997 |
RGD:6480464 |
CTD |
| G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
|
increases expression |
ISO |
18 |
1,391,751 |
1,511,865 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
decreases phosphorylation |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
|
increases expression |
ISO |
6 |
44,100,775 |
44,113,910 |
RGD:6480464 |
CTD |
| G |
Runx1t1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
|
increases expression |
ISO |
5 |
28,230,322 |
28,338,441 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
multiple interactions |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Rxrb |
retinoid X receptor beta |
|
multiple interactions |
ISO |
20 |
4,954,336 |
4,960,880 |
RGD:6480464 |
CTD |
| G |
Sec14l1 |
SEC14-like 1 (S. cerevisiae) |
|
increases expression |
ISO |
10 |
107,220,734 |
107,267,940 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
increases expression |
ISO |
13 |
13,632,596 |
13,641,605 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
increases expression |
ISO |
1 |
156,666,914 |
156,674,210 |
RGD:6480464 |
CTD |
| G |
Sf3b1 |
splicing factor 3b, subunit 1 |
|
increases expression |
ISO |
9 |
53,796,176 |
53,837,297 |
RGD:6480464 |
CTD |
| G |
Sfrp1 |
secreted frizzled-related protein 1 |
|
increases expression |
ISO |
16 |
73,030,458 |
73,067,304 |
RGD:6480464 |
CTD |
| G |
Slc7a7 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
|
decreases expression |
ISO |
15 |
32,431,748 |
32,471,526 |
RGD:6480464 |
CTD |
| G |
Smad1 |
SMAD family member 1 |
|
increases expression |
ISO |
19 |
30,348,886 |
30,409,345 |
RGD:6480464 |
CTD |
| G |
Smo |
smoothened, frizzled family receptor |
|
increases expression |
ISO |
4 |
56,623,494 |
56,645,571 |
RGD:6480464 |
CTD |
| G |
Sox17 |
SRY (sex determining region Y)-box 17 |
|
increases expression |
ISO |
5 |
15,241,405 |
15,246,904 |
RGD:6480464 |
CTD |
| G |
Sox4 |
SRY (sex determining region Y)-box 4 |
|
increases expression |
ISO |
17 |
42,172,863 |
42,177,590 |
RGD:6480464 |
CTD |
| G |
Sox6 |
SRY (sex determining region Y)-box 6 |
|
increases expression |
ISO |
1 |
173,556,966 |
174,069,437 |
RGD:6480464 |
CTD |
| G |
Sox7 |
SRY (sex determining region Y)-box 7 |
|
increases expression |
ISO |
15 |
43,207,965 |
43,214,726 |
RGD:6480464 |
CTD |
| G |
Sp2 |
Sp2 transcription factor |
|
increases expression |
ISO |
10 |
85,676,978 |
85,706,042 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
multiple interactions |
ISO |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Srgn |
serglycin |
|
increases expression |
ISO |
20 |
29,746,729 |
29,761,072 |
RGD:6480464 |
CTD |
| G |
Ssr1 |
signal sequence receptor, alpha |
|
increases expression |
ISO |
17 |
33,061,975 |
33,077,827 |
RGD:6480464 |
CTD |
| G |
Ssr3 |
signal sequence receptor, gamma |
|
increases expression |
ISO |
2 |
155,147,350 |
155,156,029 |
RGD:6480464 |
CTD |
| G |
Taz |
tafazzin |
|
multiple interactions |
ISO |
X |
160,319,389 |
160,326,974 |
RGD:6480464 |
CTD |
| G |
Tdgf1 |
teratocarcinoma-derived growth factor 1 |
|
increases expression |
ISO |
8 |
115,341,587 |
115,346,871 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
increases expression |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
increases expression |
ISO |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
affects expression |
EXP |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
affects expression |
EXP |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
increases expression |
ISO |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tmem131 |
transmembrane protein 131 |
|
increases expression |
ISO |
9 |
35,720,535 |
35,865,656 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
|
increases expression |
ISO |
6 |
136,196,746 |
136,210,410 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
decreases expression |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
increases expression |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
multiple interactions |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf19 |
tumor necrosis factor receptor superfamily, member 19 |
|
increases expression |
ISO |
15 |
40,051,695 |
40,117,968 |
RGD:6480464 |
CTD |
| G |
Tnfrsf9 |
tumor necrosis factor receptor superfamily, member 9 |
|
increases expression |
ISO |
5 |
168,071,159 |
168,099,501 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
increases expression |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
increases expression |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnfsf9 |
tumor necrosis factor (ligand) superfamily, member 9 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tob2 |
transducer of ERBB2, 2 |
|
increases expression |
ISO |
7 |
120,200,815 |
120,209,535 |
RGD:6480464 |
CTD |
| G |
Trps1 |
trichorhinophalangeal syndrome I |
|
decreases expression |
EXP |
7 |
86,855,378 |
87,076,668 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Upp1 |
uridine phosphorylase 1 |
|
decreases expression |
ISO |
14 |
89,651,264 |
89,669,630 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
multiple interactions |
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
increases expression |
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
multiple interactions |
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
multiple interactions |
ISO |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
decreases expression |
ISO |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Wnk2 |
WNK lysine deficient protein kinase 2 |
|
decreases expression |
ISO |
17 |
21,461,980 |
21,600,361 |
RGD:6480464 |
CTD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
increases expression |
ISO |
5 |
156,064,371 |
156,083,198 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
increases expression |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Zap70 |
zeta-chain (TCR) associated protein kinase 70 |
|
decreases expression |
ISO |
9 |
35,693,089 |
35,715,071 |
RGD:6480464 |
CTD |
| G |
Zbtb17 |
zinc finger and BTB domain containing 17 |
|
decreases expression |
ISO |
5 |
160,337,988 |
160,359,060 |
RGD:6480464 |
CTD |
| G |
Zmynd11 |
zinc finger, MYND-type containing 11 |
|
increases expression |
ISO |
17 |
71,296,712 |
71,418,778 |
RGD:6480464 |
CTD |
calcitriol
|
| G |
Arhgef28 |
Rho guanine nucleotide exchange factor (GEF) 28 |
|
increases expression |
ISO |
2 |
28,492,591 |
28,767,567 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
increases expression |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
decreases expression |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
multiple interactions |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
increases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Clec3b |
C-type lectin domain family 3, member B |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Clec3b |
C-type lectin domain family 3, member B |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dennd1c |
DENN/MADD domain containing 1C |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dennd1c |
DENN/MADD domain containing 1C |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dgkh |
diacylglycerol kinase, eta |
|
decreases expression |
ISO |
15 |
59,730,745 |
59,883,806 |
RGD:6480464 |
CTD |
| G |
Dgkh |
diacylglycerol kinase, eta |
|
multiple interactions |
ISO |
15 |
59,730,745 |
59,883,806 |
RGD:6480464 |
CTD |
| G |
Elp4 |
elongator acetyltransferase complex subunit 4 |
|
increases expression |
ISO |
3 |
91,154,930 |
91,309,491 |
RGD:6480464 |
CTD |
| G |
Evi5 |
ecotropic viral integration site 5 |
|
increases expression |
ISO |
14 |
2,461,189 |
2,575,313 |
RGD:6480464 |
CTD |
| G |
Fam105b |
family with sequence similarity 105, member B |
|
increases expression |
ISO |
2 |
79,431,094 |
79,454,752 |
RGD:6480464 |
CTD |
| G |
Fam198b |
family with sequence similarity 198, member B |
|
increases expression |
ISO |
2 |
171,368,285 |
171,432,819 |
RGD:6480464 |
CTD |
| G |
Fam83d |
family with sequence similarity 83, member D |
|
decreases expression |
ISO |
3 |
149,504,288 |
149,523,556 |
RGD:6480464 |
CTD |
| G |
Fam83d |
family with sequence similarity 83, member D |
|
multiple interactions |
ISO |
3 |
149,504,288 |
149,523,556 |
RGD:6480464 |
CTD |
| G |
Fhod3 |
formin homology 2 domain containing 3 |
|
increases expression |
ISO |
18 |
16,487,052 |
16,952,424 |
RGD:6480464 |
CTD |
| G |
Focad |
focadhesin |
|
increases expression |
ISO |
5 |
107,467,537 |
107,704,012 |
RGD:6480464 |
CTD |
| G |
Foxc1 |
forkhead box C1 |
|
increases expression |
ISO |
17 |
39,026,186 |
39,030,163 |
RGD:6480464 |
CTD |
| G |
Foxc1 |
forkhead box C1 |
|
multiple interactions |
ISO |
17 |
39,026,186 |
39,030,163 |
RGD:6480464 |
CTD |
| G |
Gdpd3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
|
increases expression |
ISO |
1 |
185,941,893 |
185,984,348 |
RGD:6480464 |
CTD |
| G |
Gdpd3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
|
multiple interactions |
ISO |
1 |
185,941,893 |
185,984,348 |
RGD:6480464 |
CTD |
| G |
Gem |
GTP binding protein overexpressed in skeletal muscle |
|
increases expression |
ISO |
5 |
25,809,543 |
26,008,249 |
RGD:6480464 |
CTD |
| G |
Gemin2 |
gem (nuclear organelle) associated protein 2 |
|
decreases expression |
ISO |
6 |
79,708,413 |
79,722,044 |
RGD:6480464 |
CTD |
| G |
Gemin2 |
gem (nuclear organelle) associated protein 2 |
|
multiple interactions |
ISO |
6 |
79,708,413 |
79,722,044 |
RGD:6480464 |
CTD |
| G |
Golph2 |
golgi phosphoprotein 2 |
|
increases expression |
ISO |
17 |
10,870,405 |
10,876,329 |
RGD:6480464 |
CTD |
| G |
Gpr39 |
G protein-coupled receptor 39 |
|
decreases expression |
ISO |
13 |
38,181,953 |
38,400,282 |
RGD:6480464 |
CTD |
| G |
Haus5 |
HAUS augmin-like complex, subunit 5 |
|
decreases expression |
ISO |
1 |
85,706,504 |
85,717,622 |
RGD:6480464 |
CTD |
| G |
Haus5 |
HAUS augmin-like complex, subunit 5 |
|
multiple interactions |
ISO |
1 |
85,706,504 |
85,717,622 |
RGD:6480464 |
CTD |
| G |
Hist1h2bo |
histone cluster 1, H2bo |
|
decreases expression |
ISO |
17 |
50,350,860 |
50,352,473 |
RGD:6480464 |
CTD |
| G |
Hist1h2bo |
histone cluster 1, H2bo |
|
multiple interactions |
ISO |
17 |
50,350,860 |
50,352,473 |
RGD:6480464 |
CTD |
| G |
Hrct1 |
histidine rich carboxyl terminus 1 |
|
increases expression |
ISO |
5 |
60,212,808 |
60,213,544 |
RGD:6480464 |
CTD |
| G |
Hrct1 |
histidine rich carboxyl terminus 1 |
|
multiple interactions |
ISO |
5 |
60,212,808 |
60,213,544 |
RGD:6480464 |
CTD |
| G |
Hsh2d |
hematopoietic SH2 domain containing |
|
increases expression |
ISO |
16 |
18,060,515 |
18,072,470 |
RGD:6480464 |
CTD |
| G |
Hsh2d |
hematopoietic SH2 domain containing |
|
multiple interactions |
ISO |
16 |
18,060,515 |
18,072,470 |
RGD:6480464 |
CTD |
| G |
Hspb8 |
heat shock protein B8 |
|
increases expression |
ISO |
12 |
41,407,166 |
41,421,565 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
decreases expression |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
decreases expression |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
increases expression |
ISO |
X |
31,012,921 |
31,244,127 |
RGD:6480464 |
CTD |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
multiple interactions |
ISO |
X |
31,012,921 |
31,244,127 |
RGD:6480464 |
CTD |
| G |
Htra2 |
HtrA serine peptidase 2 |
|
decreases expression |
ISO |
4 |
117,262,206 |
117,265,368 |
RGD:6480464 |
CTD |
| G |
Htra2 |
HtrA serine peptidase 2 |
|
multiple interactions |
ISO |
4 |
117,262,206 |
117,265,368 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
decreases expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
decreases expression |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ifi35 |
interferon-induced protein 35 |
|
increases expression |
ISO |
10 |
90,475,323 |
90,483,575 |
RGD:6480464 |
CTD |
| G |
Ifi35 |
interferon-induced protein 35 |
|
multiple interactions |
ISO |
10 |
90,475,323 |
90,483,575 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
decreases expression |
ISO |
1 |
238,609,171 |
238,611,236 |
RGD:6480464 |
CTD |
| G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
|
decreases expression |
ISO |
1 |
238,559,729 |
238,565,793 |
RGD:6480464 |
CTD |
| G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
|
decreases expression |
ISO |
1 |
238,571,300 |
238,576,443 |
RGD:6480464 |
CTD |
| G |
Ifltd1 |
intermediate filament tail domain containing 1 |
|
increases expression |
ISO |
4 |
183,044,223 |
183,077,661 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
affects expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
affects expression |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
multiple interactions |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
increases expression |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
multiple interactions |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
multiple interactions |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
multiple interactions |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Ism1 |
isthmin 1 homolog (zebrafish) |
|
increases expression |
ISO |
3 |
127,871,047 |
127,932,167 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
increases expression |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
multiple interactions |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Iyd |
iodotyrosine deiodinase |
|
increases expression |
ISO |
1 |
34,244,640 |
34,259,649 |
RGD:6480464 |
CTD |
| G |
Iyd |
iodotyrosine deiodinase |
|
multiple interactions |
ISO |
1 |
34,244,640 |
34,259,649 |
RGD:6480464 |
CTD |
| G |
Jag2 |
jagged 2 |
|
decreases expression |
ISO |
6 |
137,909,633 |
137,931,120 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
decreases expression |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Kcnd2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
|
increases expression |
ISO |
4 |
47,541,787 |
48,047,924 |
RGD:6480464 |
CTD |
| G |
Kcnd2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
|
multiple interactions |
ISO |
4 |
47,541,787 |
48,047,924 |
RGD:6480464 |
CTD |
| G |
Kcnd3 |
potassium voltage-gated channel, Shal-related subfamily, member 3 |
|
increases expression |
ISO |
2 |
200,709,778 |
200,924,575 |
RGD:6480464 |
CTD |
| G |
Kcnd3 |
potassium voltage-gated channel, Shal-related subfamily, member 3 |
|
multiple interactions |
ISO |
2 |
200,709,778 |
200,924,575 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
increases expression |
ISO |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
multiple interactions |
ISO |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Kcnh6 |
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
|
increases expression |
ISO |
10 |
95,400,862 |
95,421,678 |
RGD:6480464 |
CTD |
| G |
Kcnh6 |
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
|
multiple interactions |
ISO |
10 |
95,400,862 |
95,421,678 |
RGD:6480464 |
CTD |
| G |
Kcnj1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
|
increases expression |
ISO |
8 |
32,158,243 |
32,162,370 |
RGD:6480464 |
CTD |
| G |
Kcnj1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
|
multiple interactions |
ISO |
8 |
32,158,243 |
32,162,370 |
RGD:6480464 |
CTD |
| G |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
|
decreases expression |
ISO |
11 |
35,577,083 |
35,594,291 |
RGD:6480464 |
CTD |
| G |
Kcnk5 |
potassium channel, subfamily K, member 5 |
|
decreases expression |
ISO |
15 |
4,380,157 |
4,424,377 |
RGD:6480464 |
CTD |
| G |
Kcnk5 |
potassium channel, subfamily K, member 5 |
|
multiple interactions |
ISO |
15 |
4,380,157 |
4,424,377 |
RGD:6480464 |
CTD |
| G |
Kcnk9 |
potassium channel, subfamily K, member 9 |
|
increases expression |
ISO |
7 |
110,232,743 |
110,267,546 |
RGD:6480464 |
CTD |
| G |
Kcnmb4 |
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
|
increases expression |
ISO |
7 |
55,751,633 |
55,807,075 |
RGD:6480464 |
CTD |
| G |
Kcnmb4 |
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
|
multiple interactions |
ISO |
7 |
55,751,633 |
55,807,075 |
RGD:6480464 |
CTD |
| G |
Kcnn2 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
|
increases expression |
ISO |
18 |
39,560,962 |
39,705,037 |
RGD:6480464 |
CTD |
| G |
Kcnn2 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
|
multiple interactions |
ISO |
18 |
39,560,962 |
39,705,037 |
RGD:6480464 |
CTD |
| G |
Kcns3 |
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 |
|
increases expression |
ISO |
6 |
34,534,529 |
34,593,882 |
RGD:6480464 |
CTD |
| G |
Kcnt2 |
potassium channel, subfamily T, member 2 |
|
increases expression |
ISO |
13 |
53,407,504 |
53,803,012 |
RGD:6480464 |
CTD |
| G |
Kctd12 |
potassium channel tetramerisation domain containing 12 |
|
increases expression |
ISO |
15 |
86,986,827 |
86,987,810 |
RGD:6480464 |
CTD |
| G |
Kdelr3 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 |
|
increases expression |
ISO |
7 |
117,556,569 |
117,566,504 |
RGD:6480464 |
CTD |
| G |
Kdelr3 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 |
|
multiple interactions |
ISO |
7 |
117,556,569 |
117,566,504 |
RGD:6480464 |
CTD |
| G |
Kdm1a |
lysine (K)-specific demethylase 1A |
|
increases expression |
ISO |
5 |
155,299,289 |
155,358,404 |
RGD:6480464 |
CTD |
| G |
Kdm1b |
lysine (K)-specific demethylase 1B |
|
increases expression |
ISO |
17 |
23,655,643 |
23,695,480 |
RGD:6480464 |
CTD |
| G |
Kdm2b |
lysine (K)-specific demethylase 2B |
|
decreases expression |
ISO |
12 |
34,672,334 |
34,802,802 |
RGD:6480464 |
CTD |
| G |
Kdm2b |
lysine (K)-specific demethylase 2B |
|
multiple interactions |
ISO |
12 |
34,672,334 |
34,802,802 |
RGD:6480464 |
CTD |
| G |
Kdm4b |
lysine (K)-specific demethylase 4B |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Kif11 |
kinesin family member 11 |
|
decreases expression |
ISO |
1 |
241,668,938 |
241,722,847 |
RGD:6480464 |
CTD |
| G |
Kif7 |
kinesin family member 7 |
|
decreases expression |
ISO |
1 |
135,472,621 |
135,489,513 |
RGD:6480464 |
CTD |
| G |
Kif7 |
kinesin family member 7 |
|
multiple interactions |
ISO |
1 |
135,472,621 |
135,489,513 |
RGD:6480464 |
CTD |
| G |
Kifc1 |
kinesin family member C1 |
|
decreases expression |
ISO |
20 |
5,150,810 |
5,169,264 |
RGD:6480464 |
CTD |
| G |
Kifc1 |
kinesin family member C1 |
|
multiple interactions |
ISO |
20 |
5,150,810 |
5,169,264 |
RGD:6480464 |
CTD |
| G |
Klhl5 |
kelch-like family member 5 |
|
increases expression |
ISO |
14 |
45,846,061 |
45,886,040 |
RGD:6480464 |
CTD |
| G |
Kntc1 |
kinetochore associated 1 |
|
decreases expression |
ISO |
12 |
33,906,847 |
33,977,070 |
RGD:6480464 |
CTD |
| G |
Kntc1 |
kinetochore associated 1 |
|
multiple interactions |
ISO |
12 |
33,906,847 |
33,977,070 |
RGD:6480464 |
CTD |
| G |
Lbh |
limb bud and heart development |
|
increases expression |
ISO |
6 |
22,662,376 |
22,664,667 |
RGD:6480464 |
CTD |
| G |
Lcorl |
ligand dependent nuclear receptor corepressor-like |
|
decreases expression |
ISO |
14 |
70,330,344 |
70,435,179 |
RGD:6480464 |
CTD |
| G |
Lcorl |
ligand dependent nuclear receptor corepressor-like |
|
multiple interactions |
ISO |
14 |
70,330,344 |
70,435,179 |
RGD:6480464 |
CTD |
| G |
Lfng |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
|
multiple interactions |
ISO |
12 |
14,497,704 |
14,505,723 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
decreases expression |
ISO |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lgals8 |
lectin, galactoside-binding, soluble, 8 |
|
increases expression |
ISO |
17 |
68,589,595 |
68,614,014 |
RGD:6480464 |
CTD |
| G |
Lgals9 |
lectin, galactoside-binding, soluble, 9 |
|
multiple interactions |
ISO |
10 |
65,129,006 |
65,152,052 |
RGD:6480464 |
CTD |
| G |
Lgals9 |
lectin, galactoside-binding, soluble, 9 |
|
increases expression |
ISO |
10 |
65,129,006 |
65,152,052 |
RGD:6480464 |
CTD |
| G |
Lgr4 |
leucine-rich repeat-containing G protein-coupled receptor 4 |
|
increases expression |
ISO |
3 |
95,370,049 |
95,471,040 |
RGD:6480464 |
CTD |
| G |
Lhfpl2 |
lipoma HMGIC fusion partner-like 2 |
|
increases expression |
ISO |
2 |
24,407,387 |
24,489,407 |
RGD:6480464 |
CTD |
| G |
Lhfpl2 |
lipoma HMGIC fusion partner-like 2 |
|
multiple interactions |
ISO |
2 |
24,407,387 |
24,489,407 |
RGD:6480464 |
CTD |
| G |
Lhx1 |
LIM homeobox 1 |
|
increases expression |
ISO |
10 |
72,800,497 |
72,805,799 |
RGD:6480464 |
CTD |
| G |
Lhx4 |
LIM homeobox 4 |
|
multiple interactions |
ISO |
13 |
70,669,765 |
70,718,978 |
RGD:6480464 |
CTD |
| G |
Lhx4 |
LIM homeobox 4 |
|
increases expression |
ISO |
13 |
70,669,765 |
70,718,978 |
RGD:6480464 |
CTD |
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
increases expression |
ISO |
2 |
56,426,058 |
56,477,198 |
RGD:6480464 |
CTD |
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
multiple interactions |
ISO |
2 |
56,426,058 |
56,477,198 |
RGD:6480464 |
CTD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
decreases expression |
ISO |
1 |
73,728,892 |
73,767,429 |
RGD:6480464 |
CTD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
multiple interactions |
ISO |
1 |
73,728,892 |
73,767,429 |
RGD:6480464 |
CTD |
| G |
Limch1 |
LIM and calponin homology domains 1 |
|
decreases expression |
ISO |
14 |
43,722,254 |
44,049,555 |
RGD:6480464 |
CTD |
| G |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
|
increases expression |
ISO |
20 |
37,349,188 |
37,397,427 |
RGD:6480464 |
CTD |
| G |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
|
multiple interactions |
ISO |
20 |
37,349,188 |
37,397,427 |
RGD:6480464 |
CTD |
| G |
Lin7a |
lin-7 homolog a (C. elegans) |
|
decreases expression |
ISO |
7 |
45,970,622 |
46,116,986 |
RGD:6480464 |
CTD |
| G |
Lin7a |
lin-7 homolog a (C. elegans) |
|
multiple interactions |
ISO |
7 |
45,970,622 |
46,116,986 |
RGD:6480464 |
CTD |
| G |
Lin9 |
lin-9 homolog (C. elegans) |
|
decreases expression |
ISO |
13 |
96,377,751 |
96,423,915 |
RGD:6480464 |
CTD |
| G |
Lin9 |
lin-9 homolog (C. elegans) |
|
multiple interactions |
ISO |
13 |
96,377,751 |
96,423,915 |
RGD:6480464 |
CTD |
| G |
Lipg |
lipase, endothelial |
|
increases expression |
ISO |
18 |
71,795,150 |
71,816,056 |
RGD:6480464 |
CTD |
| G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
|
increases expression |
ISO |
4 |
148,071,431 |
148,130,313 |
RGD:6480464 |
CTD |
| G |
Lmnb1 |
lamin B1 |
|
multiple interactions |
ISO |
18 |
52,470,605 |
52,508,022 |
RGD:6480464 |
CTD |
| G |
Lmnb1 |
lamin B1 |
|
decreases expression |
ISO |
18 |
52,470,605 |
52,508,022 |
RGD:6480464 |
CTD |
| G |
Lmo2 |
LIM domain only 2 |
|
multiple interactions |
ISO |
3 |
89,356,199 |
89,367,641 |
RGD:6480464 |
CTD |
| G |
Lmo2 |
LIM domain only 2 |
|
increases expression |
ISO |
3 |
89,356,199 |
89,367,641 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
decreases expression |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
multiple interactions |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
LOC100360205 |
palladin |
|
decreases expression |
ISO |
16 |
31,854,459 |
31,933,792 |
RGD:6480464 |
CTD |
| G |
LOC100361295 |
methylmalonyl-Coenzyme A mutase |
|
increases expression |
ISO |
9 |
15,768,911 |
15,797,489 |
RGD:6480464 |
CTD |
| G |
LOC501033 |
similar to UPF0258 protein KIAA1024 |
|
increases expression |
ISO |
8 |
94,488,164 |
94,500,780 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
increases expression |
ISO |
18 |
47,896,674 |
47,970,829 |
RGD:6480464 |
CTD |
| G |
Lpar6 |
lysophosphatidic acid receptor 6 |
|
increases expression |
ISO |
15 |
53,875,463 |
53,877,272 |
RGD:6480464 |
CTD |
| G |
Lpgat1 |
lysophosphatidylglycerol acyltransferase 1 |
|
increases expression |
ISO |
13 |
107,782,231 |
107,851,353 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
decreases expression |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpp |
LIM domain containing preferred translocation partner in lipoma |
|
decreases expression |
ISO |
11 |
77,963,582 |
78,416,872 |
RGD:6480464 |
CTD |
| G |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
|
decreases expression |
ISO |
9 |
7,109,376 |
7,141,595 |
RGD:6480464 |
CTD |
| G |
Lrfn2 |
leucine rich repeat and fibronectin type III domain containing 2 |
|
multiple interactions |
ISO |
9 |
7,109,376 |
7,141,595 |
RGD:6480464 |
CTD |
| G |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
|
increases expression |
ISO |
4 |
128,919,630 |
129,082,488 |
RGD:6480464 |
CTD |
| G |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
|
multiple interactions |
ISO |
4 |
128,919,630 |
129,082,488 |
RGD:6480464 |
CTD |
| G |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
|
decreases expression |
ISO |
7 |
66,012,273 |
66,062,608 |
RGD:6480464 |
CTD |
| G |
Lrp10 |
low-density lipoprotein receptor-related protein 10 |
|
multiple interactions |
ISO |
15 |
32,527,394 |
32,533,554 |
RGD:6480464 |
CTD |
| G |
Lrp10 |
low-density lipoprotein receptor-related protein 10 |
|
increases expression |
ISO |
15 |
32,527,394 |
32,533,554 |
RGD:6480464 |
CTD |
| G |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
|
multiple interactions |
ISO |
1 |
206,102,750 |
206,206,350 |
RGD:6480464 |
CTD |
| G |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
|
increases expression |
ISO |
1 |
206,102,750 |
206,206,350 |
RGD:6480464 |
CTD |
| G |
Lrr1 |
leucine rich repeat protein 1 |
|
decreases expression |
ISO |
6 |
91,124,122 |
91,132,796 |
RGD:6480464 |
CTD |
| G |
Lrr1 |
leucine rich repeat protein 1 |
|
multiple interactions |
ISO |
6 |
91,124,122 |
91,132,796 |
RGD:6480464 |
CTD |
| G |
Lrrc16a |
leucine rich repeat containing 16A |
|
multiple interactions |
ISO |
17 |
47,923,987 |
48,206,590 |
RGD:6480464 |
CTD |
| G |
Lrrc16a |
leucine rich repeat containing 16A |
|
increases expression |
ISO |
17 |
47,923,987 |
48,206,590 |
RGD:6480464 |
CTD |
| G |
Lrrc29 |
leucine rich repeat containing 29 |
|
increases expression |
ISO |
19 |
35,126,618 |
35,141,282 |
RGD:6480464 |
CTD |
| G |
Ly96 |
lymphocyte antigen 96 |
|
increases expression |
ISO |
5 |
1,701,969 |
1,705,247 |
RGD:6480464 |
CTD |
| G |
Ly96 |
lymphocyte antigen 96 |
|
multiple interactions |
ISO |
5 |
1,701,969 |
1,705,247 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions |
ISO |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
increases activity |
ISO |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
March11 |
membrane-associated ring finger (C3HC4) 11 |
|
increases expression |
ISO |
2 |
77,989,651 |
78,090,956 |
RGD:6480464 |
CTD |
| G |
March11 |
membrane-associated ring finger (C3HC4) 11 |
|
multiple interactions |
ISO |
2 |
77,989,651 |
78,090,956 |
RGD:6480464 |
CTD |
| G |
Mcm5 |
minichromosome maintenance complex component 5 |
|
decreases expression |
ISO |
19 |
13,978,940 |
14,000,641 |
RGD:6480464 |
CTD |
| G |
Mcm5 |
minichromosome maintenance complex component 5 |
|
multiple interactions |
ISO |
19 |
13,978,940 |
14,000,641 |
RGD:6480464 |
CTD |
| G |
Mcm6 |
minichromosome maintenance complex component 6 |
|
multiple interactions |
ISO |
13 |
41,045,677 |
41,070,868 |
RGD:6480464 |
CTD |
| G |
Mcm6 |
minichromosome maintenance complex component 6 |
|
decreases expression |
ISO |
13 |
41,045,677 |
41,070,868 |
RGD:6480464 |
CTD |
| G |
Mcm7 |
minichromosome maintenance complex component 7 |
|
decreases expression |
ISO |
12 |
17,607,250 |
17,614,508 |
RGD:6480464 |
CTD |
| G |
Mcm7 |
minichromosome maintenance complex component 7 |
|
multiple interactions |
ISO |
12 |
17,607,250 |
17,614,508 |
RGD:6480464 |
CTD |
| G |
Mcm8 |
minichromosome maintenance complex component 8 |
|
decreases expression |
ISO |
3 |
120,614,429 |
120,644,673 |
RGD:6480464 |
CTD |
| G |
Mcm8 |
minichromosome maintenance complex component 8 |
|
multiple interactions |
ISO |
3 |
120,614,429 |
120,644,673 |
RGD:6480464 |
CTD |
| G |
Mcpt1 |
mast cell protease 1 |
|
decreases secretion |
ISO |
15 |
34,270,481 |
34,273,035 |
RGD:6480464 |
CTD |
| G |
Mdc1 |
mediator of DNA damage checkpoint 1 |
|
decreases expression |
ISO |
20 |
3,042,953 |
3,057,607 |
RGD:6480464 |
CTD |
| G |
Mdc1 |
mediator of DNA damage checkpoint 1 |
|
multiple interactions |
ISO |
20 |
3,042,953 |
3,057,607 |
RGD:6480464 |
CTD |
| G |
Mdfic |
MyoD family inhibitor domain containing |
|
increases expression |
ISO |
4 |
41,241,856 |
41,321,515 |
RGD:6480464 |
CTD |
| G |
Mdm1 |
Mdm1 nuclear protein homolog (mouse) |
|
increases expression |
ISO |
7 |
57,455,598 |
57,482,092 |
RGD:6480464 |
CTD |
| G |
Mecom |
MDS1 and EVI1 complex locus |
|
decreases expression |
ISO |
2 |
114,814,409 |
114,882,676 |
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
multiple interactions |
ISO |
10 |
86,917,525 |
86,959,080 |
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
affects localization |
ISO |
10 |
86,917,525 |
86,959,080 |
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
multiple interactions |
ISO |
10 |
86,917,525 |
86,959,080 |
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
increases expression |
ISO |
10 |
86,917,525 |
86,959,080 |
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
multiple interactions |
ISO |
10 |
86,917,525 |
86,959,080 |
RGD:6480464 |
CTD |
| G |
Med13 |
mediator complex subunit 13 |
|
increases expression |
ISO |
10 |
74,498,274 |
74,584,128 |
RGD:6480464 |
CTD |
| G |
Med14 |
mediator complex subunit 14 |
|
increases expression |
ISO |
X |
22,116,986 |
22,205,877 |
RGD:6480464 |
CTD |
| G |
Megf6 |
multiple EGF-like-domains 6 |
|
increases expression |
ISO |
5 |
171,022,566 |
171,050,436 |
RGD:6480464 |
CTD |
| G |
Megf6 |
multiple EGF-like-domains 6 |
|
multiple interactions |
ISO |
5 |
171,022,566 |
171,050,436 |
RGD:6480464 |
CTD |
| G |
Melk |
maternal embryonic leucine zipper kinase |
|
decreases expression |
ISO |
5 |
60,787,123 |
60,848,620 |
RGD:6480464 |
CTD |
| G |
Melk |
maternal embryonic leucine zipper kinase |
|
multiple interactions |
ISO |
5 |
60,787,123 |
60,848,620 |
RGD:6480464 |
CTD |
| G |
Mepe |
matrix extracellular phosphoglycoprotein |
|
decreases expression |
ISO |
14 |
6,529,356 |
6,540,902 |
RGD:6480464 |
CTD |
| G |
Mertk |
c-mer proto-oncogene tyrosine kinase |
|
increases expression |
ISO |
3 |
116,308,387 |
116,416,414 |
RGD:6480464 |
CTD |
| G |
Mertk |
c-mer proto-oncogene tyrosine kinase |
|
multiple interactions |
ISO |
3 |
116,308,387 |
116,416,414 |
RGD:6480464 |
CTD |
| G |
Metrnl |
meteorin, glial cell differentiation regulator-like |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mettl7a |
methyltransferase like 7A |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mettl7a |
methyltransferase like 7A |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mettl8 |
methyltransferase like 8 |
|
decreases expression |
ISO |
3 |
53,215,940 |
53,310,137 |
RGD:6480464 |
CTD |
| G |
Mettl8 |
methyltransferase like 8 |
|
multiple interactions |
ISO |
3 |
53,215,940 |
53,310,137 |
RGD:6480464 |
CTD |
| G |
Mex3a |
mex3 homolog A (C. elegans) |
|
decreases expression |
ISO |
2 |
180,645,985 |
180,652,134 |
RGD:6480464 |
CTD |
| G |
Mex3a |
mex3 homolog A (C. elegans) |
|
multiple interactions |
ISO |
2 |
180,645,985 |
180,652,134 |
RGD:6480464 |
CTD |
| G |
Mfi2 |
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 |
|
increases expression |
ISO |
11 |
70,706,384 |
70,728,239 |
RGD:6480464 |
CTD |
| G |
Mfsd2a |
major facilitator superfamily domain containing 2A |
|
increases expression |
ISO |
5 |
142,260,560 |
142,275,435 |
RGD:6480464 |
CTD |
| G |
Mfsd6 |
major facilitator superfamily domain containing 6 |
|
increases expression |
ISO |
9 |
45,759,998 |
45,845,858 |
RGD:6480464 |
CTD |
| G |
Mfsd6 |
major facilitator superfamily domain containing 6 |
|
multiple interactions |
ISO |
9 |
45,759,998 |
45,845,858 |
RGD:6480464 |
CTD |
| G |
Mgll |
monoglyceride lipase |
|
increases expression |
ISO |
4 |
122,822,493 |
122,922,892 |
RGD:6480464 |
CTD |
| G |
Mgll |
monoglyceride lipase |
|
multiple interactions |
ISO |
4 |
122,822,493 |
122,922,892 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
decreases expression |
EXP |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Mtbp |
Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa |
|
decreases expression |
ISO |
7 |
92,068,823 |
92,146,616 |
RGD:6480464 |
CTD |
| G |
Mtbp |
Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa |
|
multiple interactions |
ISO |
7 |
92,068,823 |
92,146,616 |
RGD:6480464 |
CTD |
| G |
Myo5b |
myosin Vb |
|
increases expression |
ISO |
18 |
71,381,068 |
71,580,824 |
RGD:6480464 |
CTD |
| G |
Myo5b |
myosin Vb |
|
multiple interactions |
ISO |
18 |
71,381,068 |
71,580,824 |
RGD:6480464 |
CTD |
| G |
Mzf1 |
myeloid zinc finger 1 |
|
multiple interactions |
ISO |
1 |
72,870,145 |
72,881,239 |
RGD:6480464 |
CTD |
| G |
Mzf1 |
myeloid zinc finger 1 |
|
increases response to substance |
ISO |
1 |
72,870,145 |
72,881,239 |
RGD:6480464 |
CTD |
| G |
Mzt1 |
mitotic spindle organizing protein 1 |
|
decreases expression |
ISO |
15 |
82,820,060 |
82,828,971 |
RGD:6480464 |
CTD |
| G |
Mzt1 |
mitotic spindle organizing protein 1 |
|
multiple interactions |
ISO |
15 |
82,820,060 |
82,828,971 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
increases expression |
ISO |
6 |
51,129,160 |
51,166,514 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
multiple interactions |
ISO |
6 |
51,129,160 |
51,166,514 |
RGD:6480464 |
CTD |
| G |
Nap1l1 |
nucleosome assembly protein 1-like 1 |
|
decreases expression |
ISO |
7 |
50,506,870 |
50,530,177 |
RGD:6480464 |
CTD |
| G |
Nap1l5 |
nucleosome assembly protein 1-like 5 |
|
decreases expression |
ISO |
4 |
87,796,429 |
87,798,296 |
RGD:6480464 |
CTD |
| G |
Nap1l5 |
nucleosome assembly protein 1-like 5 |
|
multiple interactions |
ISO |
4 |
87,796,429 |
87,798,296 |
RGD:6480464 |
CTD |
| G |
Nasp |
nuclear autoantigenic sperm protein (histone-binding) |
|
decreases expression |
ISO |
5 |
136,884,705 |
136,910,192 |
RGD:6480464 |
CTD |
| G |
Nasp |
nuclear autoantigenic sperm protein (histone-binding) |
|
multiple interactions |
ISO |
5 |
136,884,705 |
136,910,192 |
RGD:6480464 |
CTD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
increases expression |
ISO |
16 |
23,845,894 |
23,876,528 |
RGD:6480464 |
CTD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
multiple interactions |
ISO |
16 |
23,845,894 |
23,876,528 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases expression |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
multiple interactions |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nav3 |
neuron navigator 3 |
|
decreases expression |
ISO |
7 |
48,505,502 |
48,862,109 |
RGD:6480464 |
CTD |
| G |
Nav3 |
neuron navigator 3 |
|
increases expression |
ISO |
7 |
48,505,502 |
48,862,109 |
RGD:6480464 |
CTD |
| G |
Nav3 |
neuron navigator 3 |
|
multiple interactions |
ISO |
7 |
48,505,502 |
48,862,109 |
RGD:6480464 |
CTD |
| G |
Nbl1 |
neuroblastoma 1, DAN family BMP antagonist |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nbl1 |
neuroblastoma 1, DAN family BMP antagonist |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ncapd2 |
non-SMC condensin I complex, subunit D2 |
|
decreases expression |
ISO |
4 |
161,288,671 |
161,310,417 |
RGD:6480464 |
CTD |
| G |
Ncapd2 |
non-SMC condensin I complex, subunit D2 |
|
multiple interactions |
ISO |
4 |
161,288,671 |
161,310,417 |
RGD:6480464 |
CTD |
| G |
Ncapg |
non-SMC condensin I complex, subunit G |
|
decreases expression |
ISO |
14 |
70,465,952 |
70,494,296 |
RGD:6480464 |
CTD |
| G |
Ncapg |
non-SMC condensin I complex, subunit G |
|
multiple interactions |
ISO |
14 |
70,465,952 |
70,494,296 |
RGD:6480464 |
CTD |
| G |
Ncapg2 |
non-SMC condensin II complex, subunit G2 |
|
decreases expression |
ISO |
6 |
143,693,508 |
143,751,084 |
RGD:6480464 |
CTD |
| G |
Ncapg2 |
non-SMC condensin II complex, subunit G2 |
|
multiple interactions |
ISO |
6 |
143,693,508 |
143,751,084 |
RGD:6480464 |
CTD |
| G |
Nckap5 |
NCK-associated protein 5 |
|
increases expression |
ISO |
13 |
38,444,115 |
39,275,959 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
affects localization |
ISO |
6 |
27,224,396 |
27,473,926 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
6 |
27,224,396 |
27,473,926 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
affects localization |
ISO |
5 |
5,197,891 |
5,275,776 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
multiple interactions |
ISO |
5 |
5,197,891 |
5,275,776 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
multiple interactions |
ISO |
3 |
157,168,492 |
157,196,566 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
affects localization |
ISO |
3 |
157,168,492 |
157,196,566 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
multiple interactions |
ISO |
3 |
157,168,492 |
157,196,566 |
RGD:6480464 |
CTD |
| G |
Nde1 |
nudE nuclear distribution E homolog 1 (A. nidulans) |
|
decreases expression |
ISO |
10 |
777,877 |
814,260 |
RGD:6480464 |
CTD |
| G |
Nde1 |
nudE nuclear distribution E homolog 1 (A. nidulans) |
|
multiple interactions |
ISO |
10 |
777,877 |
814,260 |
RGD:6480464 |
CTD |
| G |
Ndufs1 |
NADH dehydrogenase (ubiquinone) Fe-S protein 1 |
|
multiple interactions |
EXP |
9 |
61,798,141 |
61,831,964 |
RGD:6480464 |
CTD |
| G |
Nefl |
neurofilament, light polypeptide |
|
decreases expression |
ISO |
15 |
47,636,303 |
47,640,176 |
RGD:6480464 |
CTD |
| G |
Nek2l1 |
NIMA (never in mitosis gene a)-related kinase 2-like 1 |
|
multiple interactions |
ISO |
8 |
14,245,342 |
14,246,673 |
RGD:6480464 |
CTD |
| G |
Nek2l1 |
NIMA (never in mitosis gene a)-related kinase 2-like 1 |
|
decreases expression |
ISO |
8 |
14,245,342 |
14,246,673 |
RGD:6480464 |
CTD |
| G |
Nr2c2ap |
nuclear receptor 2C2-associated protein |
|
decreases expression |
ISO |
16 |
19,771,849 |
19,774,045 |
RGD:6480464 |
CTD |
| G |
Nr2c2ap |
nuclear receptor 2C2-associated protein |
|
multiple interactions |
ISO |
16 |
19,771,849 |
19,774,045 |
RGD:6480464 |
CTD |
| G |
Ns5atp9 |
NS5A (hepatitis C virus) transactivated protein 9 |
|
decreases expression |
ISO |
8 |
70,159,283 |
70,172,116 |
RGD:6480464 |
CTD |
| G |
Ns5atp9 |
NS5A (hepatitis C virus) transactivated protein 9 |
|
multiple interactions |
ISO |
8 |
70,159,283 |
70,172,116 |
RGD:6480464 |
CTD |
| G |
Nup133 |
nucleoporin 133 |
|
increases expression |
ISO |
19 |
54,089,391 |
54,139,882 |
RGD:6480464 |
CTD |
| G |
Ocel1 |
occludin/ELL domain containing 1 |
|
multiple interactions |
ISO |
16 |
18,532,477 |
18,534,246 |
RGD:6480464 |
CTD |
| G |
Ocel1 |
occludin/ELL domain containing 1 |
|
increases expression |
ISO |
16 |
18,532,477 |
18,534,246 |
RGD:6480464 |
CTD |
| G |
Odam |
odontogenic, ameloblast asssociated |
|
multiple interactions |
ISO |
14 |
21,714,378 |
21,724,054 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
decreases expression |
ISO |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Oip5 |
Opa interacting protein 5 |
|
decreases expression |
ISO |
3 |
106,124,769 |
106,134,136 |
RGD:6480464 |
CTD |
| G |
Oip5 |
Opa interacting protein 5 |
|
multiple interactions |
ISO |
3 |
106,124,769 |
106,134,136 |
RGD:6480464 |
CTD |
| G |
Olah |
oleoyl-ACP hydrolase |
|
multiple interactions |
ISO |
17 |
85,996,338 |
86,021,192 |
RGD:6480464 |
CTD |
| G |
Olah |
oleoyl-ACP hydrolase |
|
increases expression |
ISO |
17 |
85,996,338 |
86,021,192 |
RGD:6480464 |
CTD |
| G |
Olr1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
|
decreases expression |
ISO |
4 |
166,747,228 |
166,769,340 |
RGD:6480464 |
CTD |
| G |
Omg |
oligodendrocyte-myelin glycoprotein |
|
increases expression |
ISO |
10 |
65,688,749 |
65,691,483 |
RGD:6480464 |
CTD |
| G |
Ophn1 |
oligophrenin 1 |
|
increases expression |
ISO |
X |
86,519,900 |
86,801,421 |
RGD:6480464 |
CTD |
| G |
Ophn1 |
oligophrenin 1 |
|
multiple interactions |
ISO |
X |
86,519,900 |
86,801,421 |
RGD:6480464 |
CTD |
| G |
Optn |
optineurin |
|
increases expression |
ISO |
17 |
84,298,122 |
84,348,330 |
RGD:6480464 |
CTD |
| G |
Optn |
optineurin |
|
multiple interactions |
ISO |
17 |
84,298,122 |
84,348,330 |
RGD:6480464 |
CTD |
| G |
Orc1 |
origin recognition complex, subunit 1 |
|
decreases expression |
ISO |
5 |
129,881,973 |
129,901,675 |
RGD:6480464 |
CTD |
| G |
Orc1 |
origin recognition complex, subunit 1 |
|
multiple interactions |
ISO |
5 |
129,881,973 |
129,901,675 |
RGD:6480464 |
CTD |
| G |
Orc4 |
origin recognition complex, subunit 4 |
|
increases expression |
ISO |
3 |
29,813,264 |
29,851,852 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
multiple interactions |
ISO |
5 |
80,325,042 |
80,328,194 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
increases expression |
ISO |
5 |
80,325,042 |
80,328,194 |
RGD:6480464 |
CTD |
| G |
Osbpl7 |
oxysterol binding protein-like 7 |
|
increases expression |
ISO |
10 |
85,771,941 |
85,789,490 |
RGD:6480464 |
CTD |
| G |
Osbpl7 |
oxysterol binding protein-like 7 |
|
multiple interactions |
ISO |
10 |
85,771,941 |
85,789,490 |
RGD:6480464 |
CTD |
| G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
|
multiple interactions |
ISO |
19 |
49,675,215 |
49,690,479 |
RGD:6480464 |
CTD |
| G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
|
increases expression |
ISO |
19 |
49,675,215 |
49,690,479 |
RGD:6480464 |
CTD |
| G |
Osr2 |
odd-skipped related 2 (Drosophila) |
|
increases expression |
ISO |
7 |
70,769,123 |
70,776,248 |
RGD:6480464 |
CTD |
| G |
Osr2 |
odd-skipped related 2 (Drosophila) |
|
multiple interactions |
ISO |
7 |
70,769,123 |
70,776,248 |
RGD:6480464 |
CTD |
| G |
Otud7b |
OTU domain containing 7B |
|
increases expression |
ISO |
2 |
190,905,522 |
190,964,454 |
RGD:6480464 |
CTD |
| G |
Otud7b |
OTU domain containing 7B |
|
multiple interactions |
ISO |
2 |
190,905,522 |
190,964,454 |
RGD:6480464 |
CTD |
| G |
Oxtr |
oxytocin receptor |
|
increases expression |
ISO |
4 |
148,314,089 |
148,326,797 |
RGD:6480464 |
CTD |
| G |
P2ry10 |
purinergic receptor P2Y, G-protein coupled, 10 |
|
decreases expression |
ISO |
X |
95,343,559 |
95,357,672 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
increases expression |
ISO |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
P4hb |
prolyl 4-hydroxylase, beta polypeptide |
|
multiple interactions |
EXP |
10 |
109,950,221 |
109,961,716 |
RGD:6480464 |
CTD |
| G |
Pacs1 |
phosphofurin acidic cluster sorting protein 1 |
|
increases expression |
ISO |
1 |
207,750,953 |
207,903,865 |
RGD:6480464 |
CTD |
| G |
Pacs1 |
phosphofurin acidic cluster sorting protein 1 |
|
multiple interactions |
ISO |
1 |
207,750,953 |
207,903,865 |
RGD:6480464 |
CTD |
| G |
Pacsin1 |
protein kinase C and casein kinase substrate in neurons 1 |
|
increases expression |
ISO |
20 |
5,875,450 |
5,921,738 |
RGD:6480464 |
CTD |
| G |
Pacsin1 |
protein kinase C and casein kinase substrate in neurons 1 |
|
multiple interactions |
ISO |
20 |
5,875,450 |
5,921,738 |
RGD:6480464 |
CTD |
| G |
Padi3 |
peptidyl arginine deiminase, type III |
|
increases expression |
ISO |
5 |
159,641,260 |
159,669,304 |
RGD:6480464 |
CTD |
| G |
Pak1ip1 |
PAK1 interacting protein 1 |
|
increases expression |
ISO |
17 |
29,710,400 |
29,721,477 |
RGD:6480464 |
CTD |
| G |
Pak1ip1 |
PAK1 interacting protein 1 |
|
multiple interactions |
ISO |
17 |
29,710,400 |
29,721,477 |
RGD:6480464 |
CTD |
| G |
Pak6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
|
decreases expression |
ISO |
3 |
105,141,150 |
105,191,676 |
RGD:6480464 |
CTD |
| G |
Palld |
palladin, cytoskeletal associated protein |
|
decreases expression |
ISO |
16 |
31,144,028 |
31,144,544 |
RGD:6480464 |
CTD |
| G |
Parpbp |
PARP1 binding protein |
|
decreases expression |
ISO |
7 |
24,777,634 |
24,847,083 |
RGD:6480464 |
CTD |
| G |
Parpbp |
PARP1 binding protein |
|
multiple interactions |
ISO |
7 |
24,777,634 |
24,847,083 |
RGD:6480464 |
CTD |
| G |
Pidd |
p53-induced death domain protein |
|
decreases expression |
ISO |
1 |
201,626,042 |
201,631,182 |
RGD:6480464 |
CTD |
| G |
Pidd |
p53-induced death domain protein |
|
multiple interactions |
ISO |
1 |
201,626,042 |
201,631,182 |
RGD:6480464 |
CTD |
| G |
Plch1 |
phospholipase C, eta 1 |
|
decreases expression |
ISO |
2 |
153,467,156 |
153,562,651 |
RGD:6480464 |
CTD |
| G |
Plch1 |
phospholipase C, eta 1 |
|
multiple interactions |
ISO |
2 |
153,467,156 |
153,562,651 |
RGD:6480464 |
CTD |
| G |
Pld2 |
phospholipase D2 |
|
multiple interactions |
ISO |
10 |
57,388,474 |
57,439,063 |
RGD:6480464 |
CTD |
| G |
Pld2 |
phospholipase D2 |
|
increases expression |
ISO |
10 |
57,388,474 |
57,439,063 |
RGD:6480464 |
CTD |
| G |
Plekha2 |
pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
|
increases expression |
ISO |
13 |
46,078,783 |
46,214,550 |
RGD:6480464 |
CTD |
| G |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
|
multiple interactions |
ISO |
13 |
46,078,783 |
46,214,550 |
RGD:6480464 |
CTD |
| G |
Plekha7 |
pleckstrin homology domain containing, family A member 7 |
|
increases expression |
ISO |
1 |
174,249,022 |
174,316,226 |
RGD:6480464 |
CTD |
| G |
Plekhb2 |
pleckstrin homology domain containing, family B (evectins) member 2 |
|
increases expression |
ISO |
9 |
33,585,361 |
33,618,323 |
RGD:6480464 |
CTD |
| G |
Plekhb2 |
pleckstrin homology domain containing, family B (evectins) member 2 |
|
multiple interactions |
ISO |
9 |
33,585,361 |
33,618,323 |
RGD:6480464 |
CTD |
| G |
Plekhg6 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
|
multiple interactions |
ISO |
4 |
162,185,519 |
162,201,845 |
RGD:6480464 |
CTD |
| G |
Plekhg6 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
|
increases expression |
ISO |
4 |
162,185,519 |
162,201,845 |
RGD:6480464 |
CTD |
| G |
Plekho2 |
pleckstrin homology domain containing, family O member 2 |
|
increases expression |
ISO |
8 |
69,810,804 |
69,837,126 |
RGD:6480464 |
CTD |
| G |
Plk1 |
polo-like kinase 1 |
|
multiple interactions |
ISO |
1 |
181,002,811 |
181,012,741 |
RGD:6480464 |
CTD |
| G |
Plk1 |
polo-like kinase 1 |
|
decreases expression |
ISO |
1 |
181,002,811 |
181,012,741 |
RGD:6480464 |
CTD |
| G |
Plk4 |
polo-like kinase 4 |
|
decreases expression |
ISO |
2 |
127,760,508 |
127,779,640 |
RGD:6480464 |
CTD |
| G |
Plk4 |
polo-like kinase 4 |
|
multiple interactions |
ISO |
2 |
127,760,508 |
127,779,640 |
RGD:6480464 |
CTD |
| G |
Pllp |
plasmolipin |
|
increases expression |
ISO |
19 |
10,754,737 |
10,776,134 |
RGD:6480464 |
CTD |
| G |
Pllp |
plasmolipin |
|
multiple interactions |
ISO |
19 |
10,754,737 |
10,776,134 |
RGD:6480464 |
CTD |
| G |
Plxna2 |
plexin A2 |
|
increases expression |
ISO |
13 |
110,555,958 |
110,754,672 |
RGD:6480464 |
CTD |
| G |
Plxna3 |
plexin A3 |
|
increases expression |
ISO |
X |
160,261,781 |
160,277,570 |
RGD:6480464 |
CTD |
| G |
Plxna3 |
plexin A3 |
|
multiple interactions |
ISO |
X |
160,261,781 |
160,277,570 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
decreases expression |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pmch |
pro-melanin-concentrating hormone |
|
decreases expression |
ISO |
7 |
24,778,133 |
24,779,449 |
RGD:6480464 |
CTD |
| G |
Pmch |
pro-melanin-concentrating hormone |
|
multiple interactions |
ISO |
7 |
24,778,133 |
24,779,449 |
RGD:6480464 |
CTD |
| G |
Pnkd |
paroxysmal nonkinesigenic dyskinesia |
|
decreases expression |
ISO |
9 |
73,611,610 |
73,697,690 |
RGD:6480464 |
CTD |
| G |
Pnlip |
pancreatic lipase |
|
increases expression |
ISO |
1 |
265,107,812 |
265,120,969 |
RGD:6480464 |
CTD |
| G |
Pnlip |
pancreatic lipase |
|
multiple interactions |
ISO |
1 |
265,107,812 |
265,120,969 |
RGD:6480464 |
CTD |
| G |
Poc1a |
POC1 centriolar protein homolog A (Chlamydomonas) |
|
decreases expression |
ISO |
8 |
111,413,724 |
111,472,484 |
RGD:6480464 |
CTD |
| G |
Poc1a |
POC1 centriolar protein homolog A (Chlamydomonas) |
|
multiple interactions |
ISO |
8 |
111,413,724 |
111,472,484 |
RGD:6480464 |
CTD |
| G |
Podxl |
podocalyxin-like |
|
decreases expression |
ISO |
4 |
58,611,904 |
58,658,598 |
RGD:6480464 |
CTD |
| G |
Podxl |
podocalyxin-like |
|
increases expression |
ISO |
4 |
58,611,904 |
58,658,598 |
RGD:6480464 |
CTD |
| G |
Podxl |
podocalyxin-like |
|
multiple interactions |
ISO |
4 |
58,611,904 |
58,658,598 |
RGD:6480464 |
CTD |
| G |
Pofut1 |
protein O-fucosyltransferase 1 |
|
increases expression |
ISO |
3 |
143,592,269 |
143,614,466 |
RGD:6480464 |
CTD |
| G |
Pola2 |
polymerase (DNA directed), alpha 2, accessory subunit |
|
decreases expression |
ISO |
1 |
208,573,153 |
208,597,195 |
RGD:6480464 |
CTD |
| G |
Pola2 |
polymerase (DNA directed), alpha 2, accessory subunit |
|
multiple interactions |
ISO |
1 |
208,573,153 |
208,597,195 |
RGD:6480464 |
CTD |
| G |
Pold1 |
polymerase (DNA directed), delta 1, catalytic subunit |
|
decreases expression |
ISO |
1 |
95,010,719 |
95,021,686 |
RGD:6480464 |
CTD |
| G |
Pold1 |
polymerase (DNA directed), delta 1, catalytic subunit |
|
multiple interactions |
ISO |
1 |
95,010,719 |
95,021,686 |
RGD:6480464 |
CTD |
| G |
Pole2 |
polymerase (DNA directed), epsilon 2, accessory subunit |
|
decreases expression |
ISO |
6 |
91,155,518 |
91,180,121 |
RGD:6480464 |
CTD |
| G |
Pole2 |
polymerase (DNA directed), epsilon 2, accessory subunit |
|
multiple interactions |
ISO |
6 |
91,155,518 |
91,180,121 |
RGD:6480464 |
CTD |
| G |
Polq |
polymerase (DNA directed), theta |
|
decreases expression |
ISO |
11 |
65,474,661 |
65,577,382 |
RGD:6480464 |
CTD |
| G |
Polq |
polymerase (DNA directed), theta |
|
multiple interactions |
ISO |
11 |
65,474,661 |
65,577,382 |
RGD:6480464 |
CTD |
| G |
Polr3g |
polymerase (RNA) III (DNA directed) polypeptide G |
|
decreases expression |
ISO |
2 |
9,763,378 |
9,804,285 |
RGD:6480464 |
CTD |
| G |
Polr3g |
polymerase (RNA) III (DNA directed) polypeptide G |
|
multiple interactions |
ISO |
2 |
9,763,378 |
9,804,285 |
RGD:6480464 |
CTD |
| G |
Poteg |
POTE ankyrin domain family, member G |
|
multiple interactions |
ISO |
16 |
68,964,970 |
68,984,246 |
RGD:6480464 |
CTD |
| G |
Poteg |
POTE ankyrin domain family, member G |
|
increases expression |
ISO |
16 |
68,964,970 |
68,984,246 |
RGD:6480464 |
CTD |
| G |
Pou2af1 |
POU class 2 associating factor 1 |
|
decreases expression |
ISO |
8 |
54,534,417 |
54,561,348 |
RGD:6480464 |
CTD |
| G |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
|
increases expression |
ISO |
8 |
106,061,334 |
106,155,090 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
decreases expression |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Ptpn21 |
protein tyrosine phosphatase, non-receptor type 21 |
|
increases expression |
ISO |
6 |
122,840,062 |
122,910,939 |
RGD:6480464 |
CTD |
| G |
Ptpn3 |
protein tyrosine phosphatase, non-receptor type 3 |
|
decreases expression |
ISO |
5 |
75,106,880 |
75,222,735 |
RGD:6480464 |
CTD |
| G |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
|
increases expression |
ISO |
1 |
195,263,489 |
195,303,249 |
RGD:6480464 |
CTD |
| G |
Ptprm |
protein tyrosine phosphatase, receptor type, M |
|
multiple interactions |
ISO |
9 |
105,784,922 |
106,503,148 |
RGD:6480464 |
CTD |
| G |
Ptprm |
protein tyrosine phosphatase, receptor type, M |
|
increases expression |
ISO |
9 |
105,784,922 |
106,503,148 |
RGD:6480464 |
CTD |
| G |
Ptprn2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
|
increases expression |
ISO |
6 |
143,787,884 |
144,549,042 |
RGD:6480464 |
CTD |
| G |
Ptprn2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
|
multiple interactions |
ISO |
6 |
143,787,884 |
144,549,042 |
RGD:6480464 |
CTD |
| G |
Ptprz1 |
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
|
decreases expression |
ISO |
4 |
49,267,521 |
49,468,692 |
RGD:6480464 |
CTD |
| G |
Ptrf |
polymerase I and transcript release factor |
|
multiple interactions |
ISO |
10 |
89,893,481 |
89,905,343 |
RGD:6480464 |
CTD |
| G |
Ptrf |
polymerase I and transcript release factor |
|
increases expression |
ISO |
10 |
89,893,481 |
89,905,343 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
decreases expression |
ISO |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
multiple interactions |
ISO |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Qsox1 |
quiescin Q6 sulfhydryl oxidase 1 |
|
increases expression |
ISO |
13 |
70,739,793 |
70,777,526 |
RGD:6480464 |
CTD |
| G |
Qsox1 |
quiescin Q6 sulfhydryl oxidase 1 |
|
multiple interactions |
ISO |
13 |
70,739,793 |
70,777,526 |
RGD:6480464 |
CTD |
| G |
Rab11fip1 |
RAB11 family interacting protein 1 (class I) |
|
multiple interactions |
ISO |
16 |
69,209,995 |
69,236,520 |
RGD:6480464 |
CTD |
| G |
Rab11fip1 |
RAB11 family interacting protein 1 (class I) |
|
increases expression |
ISO |
16 |
69,209,995 |
69,236,520 |
RGD:6480464 |
CTD |
| G |
Rab23 |
RAB23, member RAS oncogene family |
|
multiple interactions |
ISO |
9 |
32,465,752 |
32,486,615 |
RGD:6480464 |
CTD |
| G |
Rab23 |
RAB23, member RAS oncogene family |
|
decreases expression |
ISO |
9 |
32,465,752 |
32,486,615 |
RGD:6480464 |
CTD |
| G |
Rab4b |
RAB4B, member RAS oncogene family |
|
multiple interactions |
ISO |
1 |
82,242,920 |
82,254,443 |
RGD:6480464 |
CTD |
| G |
Rab4b |
RAB4B, member RAS oncogene family |
|
increases expression |
ISO |
1 |
82,242,920 |
82,254,443 |
RGD:6480464 |
CTD |
| G |
Rabgap1l |
RAB GTPase activating protein 1-like |
|
increases expression |
ISO |
13 |
75,685,603 |
76,275,726 |
RGD:6480464 |
CTD |
| G |
Racgap1 |
Rac GTPase-activating protein 1 |
|
decreases expression |
ISO |
7 |
138,366,356 |
138,395,716 |
RGD:6480464 |
CTD |
| G |
Racgap1 |
Rac GTPase-activating protein 1 |
|
multiple interactions |
ISO |
7 |
138,366,356 |
138,395,716 |
RGD:6480464 |
CTD |
| G |
Rad18 |
RAD18 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
4 |
148,452,664 |
148,543,743 |
RGD:6480464 |
CTD |
| G |
Rad18 |
RAD18 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
4 |
148,452,664 |
148,543,743 |
RGD:6480464 |
CTD |
| G |
Rad51 |
RAD51 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
3 |
105,625,265 |
105,650,392 |
RGD:6480464 |
CTD |
| G |
Rad51 |
RAD51 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
3 |
105,625,265 |
105,650,392 |
RGD:6480464 |
CTD |
| G |
Rad51ap1 |
RAD51 associated protein 1 |
|
multiple interactions |
ISO |
4 |
163,308,788 |
163,321,854 |
RGD:6480464 |
CTD |
| G |
Rad51ap1 |
RAD51 associated protein 1 |
|
decreases expression |
ISO |
4 |
163,308,788 |
163,321,854 |
RGD:6480464 |
CTD |
| G |
Rad51c |
Rad51 homolog c (S. cerevisiae) |
|
multiple interactions |
ISO |
10 |
75,692,205 |
75,718,369 |
RGD:6480464 |
CTD |
| G |
Rad51c |
Rad51 homolog c (S. cerevisiae) |
|
decreases expression |
ISO |
10 |
75,692,205 |
75,718,369 |
RGD:6480464 |
CTD |
| G |
Rad54l |
RAD54 like (S. cerevisiae) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rad54l |
RAD54 like (S. cerevisiae) |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rag1 |
recombination activating gene 1 |
|
increases expression |
ISO |
3 |
86,780,782 |
86,791,878 |
RGD:6480464 |
CTD |
| G |
Rai14 |
retinoic acid induced 14 |
|
multiple interactions |
ISO |
2 |
59,923,115 |
60,060,724 |
RGD:6480464 |
CTD |
| G |
Rai14 |
retinoic acid induced 14 |
|
decreases expression |
ISO |
2 |
59,923,115 |
60,060,724 |
RGD:6480464 |
CTD |
| G |
Rai2 |
retinoic acid induced 2 |
|
multiple interactions |
ISO |
X |
53,778,991 |
53,810,359 |
RGD:6480464 |
CTD |
| G |
Rai2 |
retinoic acid induced 2 |
|
increases expression |
ISO |
X |
53,778,991 |
53,810,359 |
RGD:6480464 |
CTD |
| G |
Ralgapa2 |
Ral GTPase activating protein, alpha subunit 2 (catalytic) |
|
increases expression |
ISO |
3 |
134,867,846 |
135,145,583 |
RGD:6480464 |
CTD |
| G |
Ralgapa2 |
Ral GTPase activating protein, alpha subunit 2 (catalytic) |
|
multiple interactions |
ISO |
3 |
134,867,846 |
135,145,583 |
RGD:6480464 |
CTD |
| G |
Ralgps2 |
Ral GEF with PH domain and SH3 binding motif 2 |
|
increases expression |
ISO |
13 |
72,028,711 |
72,106,310 |
RGD:6480464 |
CTD |
| G |
Ramp1 |
receptor (G protein-coupled) activity modifying protein 1 |
|
multiple interactions |
ISO |
9 |
90,402,493 |
90,450,038 |
RGD:6480464 |
CTD |
| G |
Ramp1 |
receptor (G protein-coupled) activity modifying protein 1 |
|
increases expression |
ISO |
9 |
90,402,493 |
90,450,038 |
RGD:6480464 |
CTD |
| G |
Raph1 |
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 |
|
multiple interactions |
ISO |
9 |
59,083,429 |
59,165,764 |
RGD:6480464 |
CTD |
| G |
Raph1 |
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 |
|
increases expression |
ISO |
9 |
59,083,429 |
59,165,764 |
RGD:6480464 |
CTD |
| G |
Rarres1 |
retinoic acid receptor responder (tazarotene induced) 1 |
|
increases expression |
ISO |
2 |
157,332,213 |
157,367,137 |
RGD:6480464 |
CTD |
| G |
Rasd1 |
RAS, dexamethasone-induced 1 |
|
multiple interactions |
ISO |
10 |
46,291,401 |
46,293,130 |
RGD:6480464 |
CTD |
| G |
Rasd1 |
RAS, dexamethasone-induced 1 |
|
increases expression |
ISO |
10 |
46,291,401 |
46,293,130 |
RGD:6480464 |
CTD |
| G |
Rasl11a |
RAS-like family 11 member A |
|
decreases expression |
ISO |
12 |
8,705,993 |
8,710,040 |
RGD:6480464 |
CTD |
| G |
Rasl11a |
RAS-like family 11 member A |
|
multiple interactions |
ISO |
12 |
8,705,993 |
8,710,040 |
RGD:6480464 |
CTD |
| G |
Rbmxrtl |
RNA binding motif protein, X chromosome retrogene-like |
|
decreases expression |
ISO |
19 |
31,310,317 |
31,313,892 |
RGD:6480464 |
CTD |
| G |
Rbmxrtl |
RNA binding motif protein, X chromosome retrogene-like |
|
multiple interactions |
ISO |
19 |
31,310,317 |
31,313,892 |
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
RGD1304884 |
similar to RIKEN cDNA 6430548M08 |
|
increases expression |
ISO |
19 |
50,465,554 |
50,482,061 |
RGD:6480464 |
CTD |
| G |
RGD1304884 |
similar to RIKEN cDNA 6430548M08 |
|
multiple interactions |
ISO |
19 |
50,465,554 |
50,482,061 |
RGD:6480464 |
CTD |
| G |
RGD1305254 |
similar to transmembrane protein 2 |
|
decreases expression |
ISO |
1 |
140,202,914 |
140,360,061 |
RGD:6480464 |
CTD |
| G |
RGD1310335 |
similar to RIKEN cDNA C330027C09 |
|
multiple interactions |
ISO |
11 |
53,036,752 |
53,065,176 |
RGD:6480464 |
CTD |
| G |
RGD1310335 |
similar to RIKEN cDNA C330027C09 |
|
decreases expression |
ISO |
11 |
53,036,752 |
53,065,176 |
RGD:6480464 |
CTD |
| G |
Rmi1 |
RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
17 |
12,187,351 |
12,190,862 |
RGD:6480464 |
CTD |
| G |
Rmi1 |
RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
17 |
12,187,351 |
12,190,862 |
RGD:6480464 |
CTD |
| G |
Rmi2 |
RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
10 |
4,765,965 |
4,771,062 |
RGD:6480464 |
CTD |
| G |
Rmi2 |
RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
10 |
4,765,965 |
4,771,062 |
RGD:6480464 |
CTD |
| G |
Rnf39 |
ring finger protein 39 |
|
increases expression |
ISO |
20 |
1,697,530 |
1,703,019 |
RGD:6480464 |
CTD |
| G |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
|
decreases expression |
ISO |
5 |
120,746,419 |
121,098,205 |
RGD:6480464 |
CTD |
| G |
Rp2 |
retinitis pigmentosa 2 homolog (human) |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpa2 |
replication protein A2 |
|
multiple interactions |
ISO |
5 |
152,369,550 |
152,380,370 |
RGD:6480464 |
CTD |
| G |
Rpa2 |
replication protein A2 |
|
decreases expression |
ISO |
5 |
152,369,550 |
152,380,370 |
RGD:6480464 |
CTD |
| G |
Rpia |
ribose 5-phosphate isomerase A |
|
multiple interactions |
ISO |
4 |
103,934,938 |
103,960,574 |
RGD:6480464 |
CTD |
| G |
Rpia |
ribose 5-phosphate isomerase A |
|
decreases expression |
ISO |
4 |
103,934,938 |
103,960,574 |
RGD:6480464 |
CTD |
| G |
Rplp2 |
ribosomal protein, large P2 |
|
increases expression |
ISO |
1 |
201,635,581 |
201,637,852 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
multiple interactions |
ISO |
1 |
80,176,649 |
80,182,351 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
decreases expression |
ISO |
1 |
80,176,649 |
80,182,351 |
RGD:6480464 |
CTD |
| G |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
|
increases expression |
ISO |
5 |
151,274,666 |
151,288,007 |
RGD:6480464 |
CTD |
| G |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
|
multiple interactions |
ISO |
5 |
151,274,666 |
151,288,007 |
RGD:6480464 |
CTD |
| G |
Rps6ka3 |
ribosomal protein S6 kinase polypeptide 3 |
|
increases expression |
ISO |
X |
56,722,878 |
56,825,444 |
RGD:6480464 |
CTD |
| G |
Rps6ka3 |
ribosomal protein S6 kinase polypeptide 3 |
|
multiple interactions |
ISO |
X |
56,722,878 |
56,825,444 |
RGD:6480464 |
CTD |
| G |
Rps6ka5 |
ribosomal protein S6 kinase, polypeptide 5 |
|
decreases expression |
ISO |
6 |
124,820,623 |
124,999,790 |
RGD:6480464 |
CTD |
| G |
Rrad |
Ras-related associated with diabetes |
|
decreases expression |
ISO |
19 |
272,791 |
275,957 |
RGD:6480464 |
CTD |
| G |
Rras |
related RAS viral (r-ras) oncogene homolog |
|
multiple interactions |
ISO |
1 |
95,490,730 |
95,495,462 |
RGD:6480464 |
CTD |
| G |
Rras |
related RAS viral (r-ras) oncogene homolog |
|
increases expression |
ISO |
1 |
95,490,730 |
95,495,462 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
decreases expression |
ISO |
6 |
42,350,541 |
42,356,748 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
multiple interactions |
ISO |
6 |
42,350,541 |
42,356,748 |
RGD:6480464 |
CTD |
| G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
|
decreases expression |
ISO |
6 |
44,100,775 |
44,113,910 |
RGD:6480464 |
CTD |
| G |
Rtkn2 |
rhotekin 2 |
|
decreases expression |
ISO |
20 |
21,346,889 |
21,434,160 |
RGD:6480464 |
CTD |
| G |
Rtkn2 |
rhotekin 2 |
|
multiple interactions |
ISO |
20 |
21,346,889 |
21,434,160 |
RGD:6480464 |
CTD |
| G |
Rtn2 |
reticulon 2 |
|
multiple interactions |
ISO |
1 |
78,647,099 |
78,660,389 |
RGD:6480464 |
CTD |
| G |
Rtn2 |
reticulon 2 |
|
increases expression |
ISO |
1 |
78,647,099 |
78,660,389 |
RGD:6480464 |
CTD |
| G |
Rtn4r |
reticulon 4 receptor |
|
increases expression |
ISO |
11 |
84,839,082 |
84,863,508 |
RGD:6480464 |
CTD |
| G |
Rttn |
rotatin |
|
decreases expression |
ISO |
18 |
85,830,884 |
86,012,604 |
RGD:6480464 |
CTD |
| G |
Rttn |
rotatin |
|
multiple interactions |
ISO |
18 |
85,830,884 |
86,012,604 |
RGD:6480464 |
CTD |
| G |
Runx1 |
runt-related transcription factor 1 |
|
decreases expression |
ISO |
11 |
32,623,461 |
32,725,404 |
RGD:6480464 |
CTD |
| G |
Runx1 |
runt-related transcription factor 1 |
|
increases expression |
ISO |
11 |
32,623,461 |
32,725,404 |
RGD:6480464 |
CTD |
| G |
Runx1 |
runt-related transcription factor 1 |
|
multiple interactions |
ISO |
11 |
32,623,461 |
32,725,404 |
RGD:6480464 |
CTD |
| G |
Runx1t1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
|
increases expression |
ISO |
5 |
28,230,322 |
28,338,441 |
RGD:6480464 |
CTD |
| G |
Runx1t1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
|
multiple interactions |
ISO |
5 |
28,230,322 |
28,338,441 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
decreases expression |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
multiple interactions |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
decreases expression |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
increases expression |
EXP |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
affects expression |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
affects localization |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
S100a10 |
S100 calcium binding protein A10 |
|
increases expression |
ISO |
2 |
186,645,674 |
186,654,321 |
RGD:6480464 |
CTD |
| G |
S100a10 |
S100 calcium binding protein A10 |
|
multiple interactions |
ISO |
2 |
186,645,674 |
186,654,321 |
RGD:6480464 |
CTD |
| G |
S100a3 |
S100 calcium binding protein A3 |
|
increases expression |
ISO |
2 |
182,881,054 |
182,883,821 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
increases expression |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
increases expression |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
decreases expression |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
increases expression |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
increases expression |
ISO |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
increases expression |
ISO |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
increases expression |
ISO |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
increases expression |
ISO |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
increases expression |
EXP |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
S100pbp |
S100P binding protein |
|
increases expression |
ISO |
5 |
148,309,348 |
148,350,022 |
RGD:6480464 |
CTD |
| G |
Sh3gl3 |
SH3-domain GRB2-like 3 |
|
increases expression |
ISO |
1 |
138,398,336 |
138,529,056 |
RGD:6480464 |
CTD |
| G |
Sh3pxd2a |
SH3 and PX domains 2A |
|
increases expression |
ISO |
1 |
252,601,140 |
252,796,776 |
RGD:6480464 |
CTD |
| G |
Sh3tc1 |
SH3 domain and tetratricopeptide repeats 1 |
|
increases expression |
ISO |
14 |
80,654,810 |
80,683,690 |
RGD:6480464 |
CTD |
| G |
Sh3tc1 |
SH3 domain and tetratricopeptide repeats 1 |
|
multiple interactions |
ISO |
14 |
80,654,810 |
80,683,690 |
RGD:6480464 |
CTD |
| G |
Sh3yl1 |
SH3 domain containing, Ysc84-like 1 (S. cerevisiae) |
|
increases expression |
ISO |
6 |
48,799,328 |
48,842,807 |
RGD:6480464 |
CTD |
| G |
Sh3yl1 |
SH3 domain containing, Ysc84-like 1 (S. cerevisiae) |
|
multiple interactions |
ISO |
6 |
48,799,328 |
48,842,807 |
RGD:6480464 |
CTD |
| G |
Shc2 |
SHC (Src homology 2 domain containing) transforming protein 2 |
|
multiple interactions |
ISO |
7 |
11,583,380 |
11,605,675 |
RGD:6480464 |
CTD |
| G |
Shc2 |
SHC (Src homology 2 domain containing) transforming protein 2 |
|
increases expression |
ISO |
7 |
11,583,380 |
11,605,675 |
RGD:6480464 |
CTD |
| G |
Shcbp1 |
Shc SH2-domain binding protein 1 |
|
multiple interactions |
ISO |
16 |
90,002,645 |
90,022,167 |
RGD:6480464 |
CTD |
| G |
Shcbp1 |
Shc SH2-domain binding protein 1 |
|
decreases expression |
ISO |
16 |
90,002,645 |
90,022,167 |
RGD:6480464 |
CTD |
| G |
She |
Src homology 2 domain containing E |
|
increases expression |
ISO |
2 |
182,042,669 |
182,064,466 |
RGD:6480464 |
CTD |
| G |
Shisa4 |
shisa homolog 4 (Xenopus laevis) |
|
increases expression |
ISO |
13 |
48,368,910 |
48,372,126 |
RGD:6480464 |
CTD |
| G |
Shisa4 |
shisa homolog 4 (Xenopus laevis) |
|
multiple interactions |
ISO |
13 |
48,368,910 |
48,372,126 |
RGD:6480464 |
CTD |
| G |
Shroom2 |
shroom family member 2 |
|
increases expression |
ISO |
X |
42,290,709 |
42,462,067 |
RGD:6480464 |
CTD |
| G |
Shroom2 |
shroom family member 2 |
|
multiple interactions |
ISO |
X |
42,290,709 |
42,462,067 |
RGD:6480464 |
CTD |
| G |
Si |
sucrase-isomaltase (alpha-glucosidase) |
|
decreases expression |
ISO |
2 |
163,520,975 |
163,601,280 |
RGD:6480464 |
CTD |
| G |
Si |
sucrase-isomaltase (alpha-glucosidase) |
|
multiple interactions |
ISO |
2 |
163,520,975 |
163,601,280 |
RGD:6480464 |
CTD |
| G |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
|
increases expression |
ISO |
19 |
55,622,546 |
55,775,008 |
RGD:6480464 |
CTD |
| G |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
|
multiple interactions |
ISO |
19 |
55,622,546 |
55,775,008 |
RGD:6480464 |
CTD |
| G |
Sirpa |
signal-regulatory protein alpha |
|
increases expression |
ISO |
3 |
117,210,116 |
117,247,840 |
RGD:6480464 |
CTD |
| G |
Ska1 |
spindle and kinetochore associated complex subunit 1 |
|
decreases expression |
ISO |
18 |
70,988,118 |
70,998,430 |
RGD:6480464 |
CTD |
| G |
Ska1 |
spindle and kinetochore associated complex subunit 1 |
|
multiple interactions |
ISO |
18 |
70,988,118 |
70,998,430 |
RGD:6480464 |
CTD |
| G |
Ska3 |
spindle and kinetochore associated complex subunit 3 |
|
multiple interactions |
ISO |
15 |
36,848,694 |
36,867,026 |
RGD:6480464 |
CTD |
| G |
Ska3 |
spindle and kinetochore associated complex subunit 3 |
|
decreases expression |
ISO |
15 |
36,848,694 |
36,867,026 |
RGD:6480464 |
CTD |
| G |
Skp2 |
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
2 |
58,769,164 |
58,797,229 |
RGD:6480464 |
CTD |
| G |
Skp2 |
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
2 |
58,769,164 |
58,797,229 |
RGD:6480464 |
CTD |
| G |
Skp2 |
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
2 |
58,769,164 |
58,797,229 |
RGD:6480464 |
CTD |
| G |
Sla2 |
Src-like-adaptor 2 |
|
multiple interactions |
ISO |
3 |
147,277,668 |
147,290,729 |
RGD:6480464 |
CTD |
| G |
Sla2 |
Src-like-adaptor 2 |
|
increases expression |
ISO |
3 |
147,277,668 |
147,290,729 |
RGD:6480464 |
CTD |
| G |
Slc10a2 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 2 |
|
increases expression |
ISO |
16 |
89,939,295 |
89,961,444 |
RGD:6480464 |
CTD |
| G |
Slc10a7 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 7 |
|
multiple interactions |
ISO |
19 |
31,029,928 |
31,074,346 |
RGD:6480464 |
CTD |
| G |
Slc10a7 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 7 |
|
increases expression |
ISO |
19 |
31,029,928 |
31,074,346 |
RGD:6480464 |
CTD |
| G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
|
increases activity |
EXP |
15 |
106,549,586 |
106,592,594 |
RGD:6480464 |
CTD |
| G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
|
increases expression |
EXP |
15 |
106,549,586 |
106,592,594 |
RGD:6480464 |
CTD |
| G |
Slc15a2 |
solute carrier family 15 (H+/peptide transporter), member 2 |
|
multiple interactions |
ISO |
11 |
65,819,551 |
65,849,924 |
RGD:6480464 |
CTD |
| G |
Slc15a2 |
solute carrier family 15 (H+/peptide transporter), member 2 |
|
increases expression |
ISO |
11 |
65,819,551 |
65,849,924 |
RGD:6480464 |
CTD |
| G |
Slc16a14 |
solute carrier family 16, member 14 (monocarboxylic acid transporter 14) |
|
decreases expression |
ISO |
9 |
84,170,601 |
84,195,055 |
RGD:6480464 |
CTD |
| G |
Slc16a14 |
solute carrier family 16, member 14 (monocarboxylic acid transporter 14) |
|
multiple interactions |
ISO |
9 |
84,170,601 |
84,195,055 |
RGD:6480464 |
CTD |
| G |
Slc16a5 |
solute carrier family 16, member 5 (monocarboxylic acid transporter 6) |
|
multiple interactions |
ISO |
10 |
105,543,856 |
105,556,494 |
RGD:6480464 |
CTD |
| G |
Slc16a5 |
solute carrier family 16, member 5 (monocarboxylic acid transporter 6) |
|
increases expression |
ISO |
10 |
105,543,856 |
105,556,494 |
RGD:6480464 |
CTD |
| G |
Slc17a5 |
solute carrier family 17 (anion/sugar transporter), member 5 |
|
increases expression |
ISO |
8 |
83,516,448 |
83,551,409 |
RGD:6480464 |
CTD |
| G |
Slc17a5 |
solute carrier family 17 (anion/sugar transporter), member 5 |
|
multiple interactions |
ISO |
8 |
83,516,448 |
83,551,409 |
RGD:6480464 |
CTD |
| G |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
increases expression |
ISO |
1 |
232,469,746 |
232,549,584 |
RGD:6480464 |
CTD |
| G |
Slc1a6 |
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
|
increases expression |
ISO |
7 |
12,393,284 |
12,419,893 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20 (phosphate transporter), member 1 |
|
increases expression |
EXP |
3 |
116,813,990 |
116,828,049 |
RGD:6480464 |
CTD |
| G |
Slc30a5 |
solute carrier family 30 (zinc transporter), member 5 |
|
decreases expression |
ISO |
2 |
31,607,557 |
31,637,655 |
RGD:6480464 |
CTD |
| G |
Slc30a6 |
solute carrier family 30 (zinc transporter), member 6 |
|
decreases expression |
ISO |
6 |
20,956,126 |
20,985,614 |
RGD:6480464 |
CTD |
| G |
Slc39a1 |
solute carrier family 39 (zinc transporter), member 1 |
|
decreases expression |
ISO |
2 |
182,490,501 |
182,496,068 |
RGD:6480464 |
CTD |
| G |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
|
decreases expression |
ISO |
9 |
52,168,107 |
52,217,677 |
RGD:6480464 |
CTD |
| G |
Slc39a11 |
solute carrier family 39 (metal ion transporter), member 11 |
|
decreases expression |
ISO |
10 |
102,863,399 |
103,189,081 |
RGD:6480464 |
CTD |
| G |
Slc39a13 |
solute carrier family 39 (zinc transporter), member 13 |
|
decreases expression |
ISO |
3 |
75,421,153 |
75,429,058 |
RGD:6480464 |
CTD |
| G |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
|
decreases expression |
ISO |
15 |
50,703,198 |
50,749,644 |
RGD:6480464 |
CTD |
| G |
Slc39a3 |
solute carrier family 39 (zinc transporter), member 3 |
|
decreases expression |
ISO |
7 |
10,160,746 |
10,166,609 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
decreases expression |
ISO |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Slc39a6 |
solute carrier family 39 (zinc transporter), member 6 |
|
decreases expression |
ISO |
18 |
16,353,725 |
16,374,267 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
decreases expression |
ISO |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc39a9 |
solute carrier family 39 (zinc transporter), member 9 |
|
decreases expression |
ISO |
6 |
104,407,151 |
104,442,633 |
RGD:6480464 |
CTD |
| G |
Slc41a1 |
solute carrier family 41, member 1 |
|
multiple interactions |
ISO |
13 |
44,766,706 |
44,777,526 |
RGD:6480464 |
CTD |
| G |
Slc41a1 |
solute carrier family 41, member 1 |
|
increases expression |
ISO |
13 |
44,766,706 |
44,777,526 |
RGD:6480464 |
CTD |
| G |
Slc44a5 |
solute carrier family 44, member 5 |
|
increases expression |
ISO |
2 |
252,123,384 |
252,176,449 |
RGD:6480464 |
CTD |
| G |
Slc51a |
solute carrier family 51, alpha subunit |
|
decreases expression |
ISO |
11 |
70,115,430 |
70,129,828 |
RGD:6480464 |
CTD |
| G |
Slco1a2 |
solute carrier organic anion transporter family, member 1A2 |
|
increases expression |
ISO |
4 |
179,790,209 |
179,851,288 |
RGD:6480464 |
CTD |
| G |
Snx18 |
sorting nexin 18 |
|
increases expression |
ISO |
2 |
45,014,383 |
45,040,586 |
RGD:6480464 |
CTD |
| G |
Snx25 |
sorting nexin 25 |
|
multiple interactions |
ISO |
16 |
49,415,658 |
49,518,663 |
RGD:6480464 |
CTD |
| G |
Snx25 |
sorting nexin 25 |
|
increases expression |
ISO |
16 |
49,415,658 |
49,518,663 |
RGD:6480464 |
CTD |
| G |
Snx30 |
sorting nexin family member 30 |
|
increases expression |
ISO |
5 |
77,924,034 |
78,037,119 |
RGD:6480464 |
CTD |
| G |
Snx33 |
sorting nexin 33 |
|
increases expression |
ISO |
8 |
60,663,024 |
60,673,400 |
RGD:6480464 |
CTD |
| G |
Snx33 |
sorting nexin 33 |
|
multiple interactions |
ISO |
8 |
60,663,024 |
60,673,400 |
RGD:6480464 |
CTD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
decreases expression |
ISO |
7 |
32,605,714 |
32,608,323 |
RGD:6480464 |
CTD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
increases expression |
ISO |
7 |
32,605,714 |
32,608,323 |
RGD:6480464 |
CTD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
multiple interactions |
ISO |
7 |
32,605,714 |
32,608,323 |
RGD:6480464 |
CTD |
| G |
Sos2 |
son of sevenless homolog 2 (Drosophila) |
|
increases expression |
ISO |
6 |
91,609,463 |
91,722,481 |
RGD:6480464 |
CTD |
| G |
Sost |
sclerostin |
|
multiple interactions |
ISO |
10 |
91,023,712 |
91,026,759 |
RGD:6480464 |
CTD |
| G |
Sowaha |
sosondowah ankyrin repeat domain family member A |
|
increases expression |
ISO |
10 |
38,946,385 |
38,948,498 |
RGD:6480464 |
CTD |
| G |
Sox4 |
SRY (sex determining region Y)-box 4 |
|
increases expression |
ISO |
17 |
42,172,863 |
42,177,590 |
RGD:6480464 |
CTD |
| G |
Sp4 |
Sp4 transcription factor |
|
decreases expression |
ISO |
6 |
145,553,512 |
145,619,389 |
RGD:6480464 |
CTD |
| G |
Sp4 |
Sp4 transcription factor |
|
multiple interactions |
ISO |
6 |
145,553,512 |
145,619,389 |
RGD:6480464 |
CTD |
| G |
Spag1 |
sperm associated antigen 1 |
|
increases expression |
ISO |
7 |
71,699,341 |
71,759,373 |
RGD:6480464 |
CTD |
| G |
Spag1 |
sperm associated antigen 1 |
|
multiple interactions |
ISO |
7 |
71,699,341 |
71,759,373 |
RGD:6480464 |
CTD |
| G |
Spag5 |
sperm associated antigen 5 |
|
multiple interactions |
ISO |
10 |
64,313,146 |
64,330,975 |
RGD:6480464 |
CTD |
| G |
Spag5 |
sperm associated antigen 5 |
|
decreases expression |
ISO |
10 |
64,313,146 |
64,330,975 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
increases expression |
EXP |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Sparcl1 |
SPARC-like 1 (hevin) |
|
increases expression |
ISO |
14 |
6,766,347 |
6,797,581 |
RGD:6480464 |
CTD |
| G |
Spata5 |
spermatogenesis associated 5 |
|
decreases expression |
ISO |
2 |
123,962,875 |
124,154,127 |
RGD:6480464 |
CTD |
| G |
Spata5 |
spermatogenesis associated 5 |
|
multiple interactions |
ISO |
2 |
123,962,875 |
124,154,127 |
RGD:6480464 |
CTD |
| G |
Spc24 |
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
8 |
20,854,434 |
20,859,121 |
RGD:6480464 |
CTD |
| G |
Spc24 |
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
8 |
20,854,434 |
20,859,121 |
RGD:6480464 |
CTD |
| G |
Spc25 |
SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
3 |
51,361,185 |
51,374,357 |
RGD:6480464 |
CTD |
| G |
Spc25 |
SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
3 |
51,361,185 |
51,374,357 |
RGD:6480464 |
CTD |
| G |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
|
increases expression |
ISO |
10 |
48,118,178 |
48,309,501 |
RGD:6480464 |
CTD |
| G |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
|
multiple interactions |
ISO |
10 |
48,118,178 |
48,309,501 |
RGD:6480464 |
CTD |
| G |
Spin4 |
spindlin family, member 4 |
|
decreases expression |
ISO |
X |
82,564,580 |
82,565,329 |
RGD:6480464 |
CTD |
| G |
Spin4 |
spindlin family, member 4 |
|
multiple interactions |
ISO |
X |
82,564,580 |
82,565,329 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sprr1a |
small proline-rich protein 1A |
|
decreases expression |
ISO |
2 |
185,463,951 |
185,465,849 |
RGD:6480464 |
CTD |
| G |
Spry2 |
sprouty homolog 2 (Drosophila) |
|
increases expression |
ISO |
15 |
90,009,109 |
90,011,940 |
RGD:6480464 |
CTD |
| G |
Sptlc2 |
serine palmitoyltransferase, long chain base subunit 2 |
|
increases expression |
ISO |
6 |
111,546,037 |
111,622,959 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
increases expression |
ISO |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
decreases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srek1ip1 |
SREK1-interacting protein 1 |
|
increases expression |
ISO |
2 |
35,825,856 |
35,849,470 |
RGD:6480464 |
CTD |
| G |
Srgap1 |
SLIT-ROBO Rho GTPase activating protein 1 |
|
increases expression |
ISO |
7 |
61,372,294 |
61,633,209 |
RGD:6480464 |
CTD |
| G |
Srgap2 |
SLIT-ROBO Rho GTPase activating protein 2 |
|
increases expression |
ISO |
13 |
44,239,946 |
44,452,446 |
RGD:6480464 |
CTD |
| G |
Sri |
sorcin |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Srrm3 |
serine/arginine repetitive matrix 3 |
|
multiple interactions |
ISO |
12 |
21,927,594 |
22,005,675 |
RGD:6480464 |
CTD |
| G |
Srrm3 |
serine/arginine repetitive matrix 3 |
|
increases expression |
ISO |
12 |
21,927,594 |
22,005,675 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
increases expression |
ISO |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
multiple interactions |
ISO |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Tbc1d2 |
TBC1 domain family, member 2 |
|
increases expression |
ISO |
5 |
63,177,831 |
63,225,245 |
RGD:6480464 |
CTD |
| G |
Tbc1d2 |
TBC1 domain family, member 2 |
|
multiple interactions |
ISO |
5 |
63,177,831 |
63,225,245 |
RGD:6480464 |
CTD |
| G |
Tg |
thyroglobulin |
|
multiple interactions |
ISO |
7 |
104,035,776 |
104,220,754 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
increases expression |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
multiple interactions |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
increases expression |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
multiple interactions |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
multiple interactions |
ISO |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
increases expression |
ISO |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tgm1 |
transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) |
|
decreases expression |
ISO |
15 |
33,846,367 |
33,859,615 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases expression |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
multiple interactions |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tgm3 |
transglutaminase 3, E polypeptide |
|
multiple interactions |
ISO |
3 |
117,622,727 |
117,659,103 |
RGD:6480464 |
CTD |
| G |
Tgm3 |
transglutaminase 3, E polypeptide |
|
decreases expression |
ISO |
3 |
117,622,727 |
117,659,103 |
RGD:6480464 |
CTD |
| G |
Tgm4 |
transglutaminase 4 (prostate) |
|
decreases expression |
ISO |
8 |
127,782,460 |
127,819,491 |
RGD:6480464 |
CTD |
| G |
Tgm4 |
transglutaminase 4 (prostate) |
|
multiple interactions |
ISO |
8 |
127,782,460 |
127,819,491 |
RGD:6480464 |
CTD |
| G |
Thpo |
thrombopoietin |
|
decreases expression |
ISO |
11 |
82,412,552 |
82,417,807 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
increases expression |
ISO |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
decreases expression |
ISO |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Tinag |
tubulointerstitial nephritis antigen |
|
increases expression |
ISO |
8 |
81,947,234 |
82,032,994 |
RGD:6480464 |
CTD |
| G |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
|
increases expression |
ISO |
5 |
149,198,274 |
149,207,653 |
RGD:6480464 |
CTD |
| G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
|
increases expression |
ISO |
2 |
155,312,341 |
155,339,357 |
RGD:6480464 |
CTD |
| G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
|
multiple interactions |
ISO |
2 |
155,312,341 |
155,339,357 |
RGD:6480464 |
CTD |
| G |
Tjp3 |
tight junction protein 3 |
|
multiple interactions |
ISO |
7 |
9,917,359 |
9,930,081 |
RGD:6480464 |
CTD |
| G |
Tjp3 |
tight junction protein 3 |
|
increases expression |
ISO |
7 |
9,917,359 |
9,930,081 |
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tlr3 |
toll-like receptor 3 |
|
increases expression |
ISO |
16 |
50,112,910 |
50,126,371 |
RGD:6480464 |
CTD |
| G |
Tlr3 |
toll-like receptor 3 |
|
multiple interactions |
ISO |
16 |
50,112,910 |
50,126,371 |
RGD:6480464 |
CTD |
| G |
Tm4sf1 |
transmembrane 4 L six family member 1 |
|
multiple interactions |
ISO |
2 |
146,521,188 |
146,530,382 |
RGD:6480464 |
CTD |
| G |
Tm4sf1 |
transmembrane 4 L six family member 1 |
|
decreases expression |
ISO |
2 |
146,521,188 |
146,530,382 |
RGD:6480464 |
CTD |
| G |
Tmc4 |
transmembrane channel-like 4 |
|
increases expression |
ISO |
1 |
63,852,716 |
63,864,605 |
RGD:6480464 |
CTD |
| G |
Tmc4 |
transmembrane channel-like 4 |
|
multiple interactions |
ISO |
1 |
63,852,716 |
63,864,605 |
RGD:6480464 |
CTD |
| G |
Tmcc3 |
transmembrane and coiled-coil domain family 3 |
|
increases expression |
ISO |
7 |
31,691,945 |
31,764,354 |
RGD:6480464 |
CTD |
| G |
Tmcc3 |
transmembrane and coiled-coil domain family 3 |
|
multiple interactions |
ISO |
7 |
31,691,945 |
31,764,354 |
RGD:6480464 |
CTD |
| G |
Tmco3 |
transmembrane and coiled-coil domains 3 |
|
increases expression |
ISO |
16 |
81,072,647 |
81,111,007 |
RGD:6480464 |
CTD |
| G |
Tmco3 |
transmembrane and coiled-coil domains 3 |
|
multiple interactions |
ISO |
16 |
81,072,647 |
81,111,007 |
RGD:6480464 |
CTD |
| G |
Tmem100 |
transmembrane protein 100 |
|
increases expression |
ISO |
10 |
78,446,217 |
78,452,072 |
RGD:6480464 |
CTD |
| G |
Tmem100 |
transmembrane protein 100 |
|
multiple interactions |
ISO |
10 |
78,446,217 |
78,452,072 |
RGD:6480464 |
CTD |
| G |
Tmem102 |
transmembrane protein 102 |
|
increases expression |
ISO |
10 |
56,624,941 |
56,636,020 |
RGD:6480464 |
CTD |
| G |
Tmem102 |
transmembrane protein 102 |
|
multiple interactions |
ISO |
10 |
56,624,941 |
56,636,020 |
RGD:6480464 |
CTD |
| G |
Tmem106b |
transmembrane protein 106B |
|
multiple interactions |
ISO |
4 |
38,398,245 |
38,415,059 |
RGD:6480464 |
CTD |
| G |
Tmem106b |
transmembrane protein 106B |
|
increases expression |
ISO |
4 |
38,398,245 |
38,415,059 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Traip |
TRAF-interacting protein |
|
multiple interactions |
ISO |
8 |
113,220,855 |
113,240,631 |
RGD:6480464 |
CTD |
| G |
Tram2 |
translocation associated membrane protein 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Trank1 |
tetratricopeptide repeat and ankyrin repeat containing 1 |
|
increases expression |
ISO |
8 |
115,701,554 |
115,781,013 |
RGD:6480464 |
CTD |
| G |
Trank1 |
tetratricopeptide repeat and ankyrin repeat containing 1 |
|
multiple interactions |
ISO |
8 |
115,701,554 |
115,781,013 |
RGD:6480464 |
CTD |
| G |
Trex1 |
three prime repair exonuclease 1 |
|
decreases expression |
ISO |
8 |
114,071,508 |
114,072,509 |
RGD:6480464 |
CTD |
| G |
Trex1 |
three prime repair exonuclease 1 |
|
multiple interactions |
ISO |
8 |
114,071,508 |
114,072,509 |
RGD:6480464 |
CTD |
| G |
Trib1 |
tribbles homolog 1 (Drosophila) |
|
increases expression |
ISO |
7 |
96,442,239 |
96,448,785 |
RGD:6480464 |
CTD |
| G |
Trim13 |
tripartite motif-containing 13 |
|
increases expression |
ISO |
15 |
40,743,520 |
40,752,138 |
RGD:6480464 |
CTD |
| G |
Trim13 |
tripartite motif-containing 13 |
|
multiple interactions |
ISO |
15 |
40,743,520 |
40,752,138 |
RGD:6480464 |
CTD |
| G |
Trim16 |
tripartite motif-containing 16 |
|
decreases expression |
ISO |
10 |
48,987,004 |
49,009,696 |
RGD:6480464 |
CTD |
| G |
Trim2 |
tripartite motif-containing 2 |
|
increases expression |
ISO |
2 |
175,908,880 |
175,974,709 |
RGD:6480464 |
CTD |
| G |
Trim24 |
tripartite motif-containing 24 |
|
increases expression |
ISO |
4 |
65,490,076 |
65,543,305 |
RGD:6480464 |
CTD |
| G |
Trim59 |
tripartite motif-containing 59 |
|
decreases expression |
ISO |
2 |
159,016,206 |
159,027,069 |
RGD:6480464 |
CTD |
| G |
Trim59 |
tripartite motif-containing 59 |
|
multiple interactions |
ISO |
2 |
159,016,206 |
159,027,069 |
RGD:6480464 |
CTD |
| G |
Trim6 |
tripartite motif containing 6 |
|
increases expression |
ISO |
1 |
162,059,220 |
162,094,672 |
RGD:6480464 |
CTD |
| G |
Trip13 |
thyroid hormone receptor interactor 13 |
|
multiple interactions |
ISO |
1 |
30,165,330 |
30,210,271 |
RGD:6480464 |
CTD |
| G |
Trip13 |
thyroid hormone receptor interactor 13 |
|
decreases expression |
ISO |
1 |
30,165,330 |
30,210,271 |
RGD:6480464 |
CTD |
| G |
Troap |
trophinin associated protein |
|
decreases expression |
ISO |
7 |
137,852,698 |
137,860,157 |
RGD:6480464 |
CTD |
| G |
Troap |
trophinin associated protein |
|
multiple interactions |
ISO |
7 |
137,852,698 |
137,860,157 |
RGD:6480464 |
CTD |
| G |
Trpv5 |
transient receptor potential cation channel, subfamily V, member 5 |
|
increases expression |
ISO |
4 |
69,361,051 |
69,387,346 |
RGD:6480464 |
CTD |
| G |
Trpv5 |
transient receptor potential cation channel, subfamily V, member 5 |
|
increases expression |
EXP |
4 |
69,361,051 |
69,387,346 |
RGD:6480464 |
CTD |
| G |
Trpv6 |
transient receptor potential cation channel, subfamily V, member 6 |
|
multiple interactions |
ISO |
4 |
69,331,973 |
69,347,633 |
RGD:6480464 |
CTD |
| G |
Trpv6 |
transient receptor potential cation channel, subfamily V, member 6 |
|
multiple interactions |
ISO |
4 |
69,331,973 |
69,347,633 |
RGD:6480464 |
CTD |
| G |
Trpv6 |
transient receptor potential cation channel, subfamily V, member 6 |
|
increases expression |
ISO |
4 |
69,331,973 |
69,347,633 |
RGD:6480464 |
CTD |
| G |
Tsc22d3 |
TSC22 domain family, member 3 |
|
decreases expression |
ISO |
X |
128,336,408 |
128,340,027 |
RGD:6480464 |
CTD |
| G |
Tsku |
tsukushi, small leucine rich proteoglycan |
|
increases expression |
ISO |
1 |
155,611,069 |
155,622,378 |
RGD:6480464 |
CTD |
| G |
Tsku |
tsukushi, small leucine rich proteoglycan |
|
multiple interactions |
ISO |
1 |
155,611,069 |
155,622,378 |
RGD:6480464 |
CTD |
| G |
Tslp |
thymic stromal lymphopoietin |
|
increases expression |
ISO |
18 |
25,268,082 |
25,274,214 |
RGD:6480464 |
CTD |
| G |
Tslp |
thymic stromal lymphopoietin |
|
increases expression |
ISO |
18 |
25,268,082 |
25,274,214 |
RGD:6480464 |
CTD |
| G |
Tslp |
thymic stromal lymphopoietin |
|
multiple interactions |
ISO |
18 |
25,268,082 |
25,274,214 |
RGD:6480464 |
CTD |
| G |
Tspan31 |
tetraspanin 31 |
|
increases expression |
ISO |
7 |
67,019,168 |
67,022,042 |
RGD:6480464 |
CTD |
| G |
Tspan31 |
tetraspanin 31 |
|
multiple interactions |
ISO |
7 |
67,019,168 |
67,022,042 |
RGD:6480464 |
CTD |
| G |
Tspan5 |
tetraspanin 5 |
|
decreases expression |
ISO |
2 |
236,314,737 |
236,487,072 |
RGD:6480464 |
CTD |
| G |
Ttc39a |
tetratricopeptide repeat domain 39A |
|
increases expression |
ISO |
5 |
130,761,328 |
130,800,627 |
RGD:6480464 |
CTD |
| G |
Ttc39a |
tetratricopeptide repeat domain 39A |
|
multiple interactions |
ISO |
5 |
130,761,328 |
130,800,627 |
RGD:6480464 |
CTD |
| G |
Ttk |
Ttk protein kinase |
|
multiple interactions |
ISO |
8 |
88,906,665 |
88,944,613 |
RGD:6480464 |
CTD |
| G |
Ttk |
Ttk protein kinase |
|
decreases expression |
ISO |
8 |
88,906,665 |
88,944,613 |
RGD:6480464 |
CTD |
| G |
Tub |
tubby homolog (mouse) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tub |
tubby homolog (mouse) |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tuba1a |
tubulin, alpha 1A |
|
increases expression |
ISO |
7 |
137,729,405 |
137,733,071 |
RGD:6480464 |
CTD |
| G |
Tubb6 |
tubulin, beta 6 class V |
|
increases expression |
ISO |
18 |
63,919,776 |
63,929,415 |
RGD:6480464 |
CTD |
| G |
Tubb6 |
tubulin, beta 6 class V |
|
multiple interactions |
ISO |
18 |
63,919,776 |
63,929,415 |
RGD:6480464 |
CTD |
| G |
Txndc11 |
thioredoxin domain containing 11 |
|
increases expression |
ISO |
10 |
4,404,433 |
4,486,095 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
multiple interactions |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
decreases expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
decreases expression |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
multiple interactions |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Uhrf1bp1 |
UHRF1 binding protein 1 |
|
increases expression |
ISO |
20 |
6,067,567 |
6,108,468 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
multiple interactions |
EXP |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
multiple interactions |
EXP |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
increases expression |
EXP |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
increases expression |
EXP |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
increases expression |
EXP |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
affects expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vgll4 |
vestigial like 4 (Drosophila) |
|
increases expression |
ISO |
4 |
150,995,533 |
151,055,736 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
increases expression |
ISO |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
decreases expression |
ISO |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
multiple interactions |
ISO |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Vps13a |
vacuolar protein sorting 13 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
1 |
219,987,826 |
220,221,494 |
RGD:6480464 |
CTD |
| G |
Vps13a |
vacuolar protein sorting 13 homolog A (S. cerevisiae) |
|
multiple interactions |
ISO |
1 |
219,987,826 |
220,221,494 |
RGD:6480464 |
CTD |
| G |
Vrk1 |
vaccinia related kinase 1 |
|
decreases expression |
ISO |
6 |
130,181,610 |
130,249,361 |
RGD:6480464 |
CTD |
| G |
Vrk1 |
vaccinia related kinase 1 |
|
multiple interactions |
ISO |
6 |
130,181,610 |
130,249,361 |
RGD:6480464 |
CTD |
| G |
Vsnl1 |
visinin-like 1 |
|
decreases expression |
ISO |
6 |
34,770,053 |
34,895,220 |
RGD:6480464 |
CTD |
| G |
Vwa5a |
von Willebrand factor A domain containing 5A |
|
increases expression |
ISO |
8 |
40,850,240 |
40,884,975 |
RGD:6480464 |
CTD |
| G |
Vwa5a |
von Willebrand factor A domain containing 5A |
|
multiple interactions |
ISO |
8 |
40,850,240 |
40,884,975 |
RGD:6480464 |
CTD |
| G |
Wdfy2 |
WD repeat and FYVE domain containing 2 |
|
multiple interactions |
ISO |
15 |
42,095,912 |
42,222,222 |
RGD:6480464 |
CTD |
| G |
Wdfy2 |
WD repeat and FYVE domain containing 2 |
|
increases expression |
ISO |
15 |
42,095,912 |
42,222,222 |
RGD:6480464 |
CTD |
| G |
Wdhd1 |
WD repeat and HMG-box DNA binding protein 1 |
|
decreases expression |
ISO |
15 |
23,194,973 |
23,228,773 |
RGD:6480464 |
CTD |
| G |
Wdhd1 |
WD repeat and HMG-box DNA binding protein 1 |
|
multiple interactions |
ISO |
15 |
23,194,973 |
23,228,773 |
RGD:6480464 |
CTD |
| G |
Wdr34 |
WD repeat domain 34 |
|
decreases expression |
ISO |
3 |
9,021,833 |
9,037,243 |
RGD:6480464 |
CTD |
| G |
Wdr34 |
WD repeat domain 34 |
|
multiple interactions |
ISO |
3 |
9,021,833 |
9,037,243 |
RGD:6480464 |
CTD |
| G |
Wdr36 |
WD repeat domain 36 |
|
increases expression |
ISO |
18 |
25,294,369 |
25,322,294 |
RGD:6480464 |
CTD |
| G |
Wdr62 |
WD repeat domain 62 |
|
decreases expression |
ISO |
1 |
85,448,728 |
85,482,510 |
RGD:6480464 |
CTD |
| G |
Wdr62 |
WD repeat domain 62 |
|
multiple interactions |
ISO |
1 |
85,448,728 |
85,482,510 |
RGD:6480464 |
CTD |
| G |
Wdr72 |
WD repeat domain 72 |
|
increases expression |
ISO |
8 |
78,891,358 |
79,050,751 |
RGD:6480464 |
CTD |
| G |
Wdr76 |
WD repeat domain 76 |
|
decreases expression |
ISO |
3 |
108,285,809 |
108,317,646 |
RGD:6480464 |
CTD |
| G |
Wdr76 |
WD repeat domain 76 |
|
multiple interactions |
ISO |
3 |
108,285,809 |
108,317,646 |
RGD:6480464 |
CTD |
| G |
Wdsub1 |
WD repeat, sterile alpha motif and U-box domain containing 1 |
|
increases expression |
ISO |
3 |
41,572,560 |
41,602,917 |
RGD:6480464 |
CTD |
| G |
Whsc1 |
Wolf-Hirschhorn syndrome candidate 1 |
|
decreases expression |
ISO |
14 |
82,528,213 |
82,580,192 |
RGD:6480464 |
CTD |
| G |
Whsc1 |
Wolf-Hirschhorn syndrome candidate 1 |
|
multiple interactions |
ISO |
14 |
82,528,213 |
82,580,192 |
RGD:6480464 |
CTD |
| G |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
|
increases expression |
ISO |
10 |
98,722,266 |
98,753,713 |
RGD:6480464 |
CTD |
| G |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
|
multiple interactions |
ISO |
10 |
98,722,266 |
98,753,713 |
RGD:6480464 |
CTD |
| G |
Wnk2 |
WNK lysine deficient protein kinase 2 |
|
increases expression |
ISO |
17 |
21,461,980 |
21,600,361 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
increases expression |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
|
decreases expression |
ISO |
7 |
123,533,713 |
123,554,333 |
RGD:6480464 |
CTD |
| G |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
|
increases expression |
ISO |
7 |
123,533,713 |
123,554,333 |
RGD:6480464 |
CTD |
| G |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
|
multiple interactions |
ISO |
7 |
123,533,713 |
123,554,333 |
RGD:6480464 |
CTD |
| G |
Wnt9a |
wingless-type MMTV integration site family, member 9A |
|
increases expression |
ISO |
10 |
45,613,668 |
45,641,488 |
RGD:6480464 |
CTD |
| G |
Wnt9a |
wingless-type MMTV integration site family, member 9A |
|
multiple interactions |
ISO |
10 |
45,613,668 |
45,641,488 |
RGD:6480464 |
CTD |
| G |
Wrap53 |
WD repeat containing, antisense to TP53 |
|
decreases expression |
ISO |
10 |
56,380,914 |
56,398,501 |
RGD:6480464 |
CTD |
| G |
Wrap53 |
WD repeat containing, antisense to TP53 |
|
multiple interactions |
ISO |
10 |
56,380,914 |
56,398,501 |
RGD:6480464 |
CTD |
| G |
Wsb1 |
WD repeat and SOCS box-containing 1 |
|
multiple interactions |
ISO |
10 |
65,427,131 |
65,443,208 |
RGD:6480464 |
CTD |
| G |
Wsb1 |
WD repeat and SOCS box-containing 1 |
|
increases expression |
ISO |
10 |
65,427,131 |
65,443,208 |
RGD:6480464 |
CTD |
| G |
Xcl1 |
chemokine (C motif) ligand 1 |
|
increases expression |
ISO |
13 |
80,691,195 |
80,694,638 |
RGD:6480464 |
CTD |
| G |
Xkr5 |
XK, Kell blood group complex subunit-related family, member 5 |
|
increases expression |
ISO |
16 |
75,677,746 |
75,695,654 |
RGD:6480464 |
CTD |
| G |
Xrcc3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
|
decreases expression |
ISO |
6 |
136,594,276 |
136,602,069 |
RGD:6480464 |
CTD |
| G |
Zfp167 |
zinc finger protein 167 |
|
increases expression |
ISO |
8 |
127,591,874 |
127,625,629 |
RGD:6480464 |
CTD |
Term paths to the root
|